Special Diabetes Program for Indians, 68630-68639 [2023-22057]
Download as PDF
lotter on DSK11XQN23PROD with NOTICES1
68630
Federal Register / Vol. 88, No. 191 / Wednesday, October 4, 2023 / Notices
access services to ensure AA and NHPI
communities can access Federal
programs and services; and strategies to
increase public-and private-sector
collaboration, and community
involvement in improving the safety
and socioeconomic, health, educational,
occupational, and environmental wellbeing of AA and NHPI communities.
Information is available on the
President’s Advisory Commission on
Asian Americans, Native Hawaiians,
and Pacific Islanders website at https://
www.hhs.gov/about/whiaanhpi/
commission/. The names of
the 25 members of the President’s
Advisory Commission on Asian
Americans, Native Hawaiians, and
Pacific Islanders are available at https://
www.hhs.gov/about/whiaanhpi/
commission/commissioners/.
Purpose of Meeting: The President’s
Advisory Commission on Asian
Americans, Native Hawaiians, and
Pacific Islanders, authorized by
Executive Order 14031, will meet to
discuss full and draft recommendations
by the Commission’s six Subcommittees
on ways to advance equity, justice, and
opportunity for Asian American, Native
Hawaiian, and Pacific Islander
communities. The Subcommittees are:
Belonging, Inclusion, Anti-Asian Hate,
Anti-Discrimination; Data
Disaggregation; Language Access;
Economic Equity; Health Equity; and
Immigration and Citizenship Status.
Background: Asian American, Native
Hawaiian, and Pacific Islander
communities are among the fastest
growing racial and ethnic populations
in the United States according to the
U.S. Census Bureau. However, in recent
years, AA and NHPI individuals have
faced increasing hate crimes and
incidents that threaten their safety, as
well as harmful stereotypes that often
ignore socioeconomic, health, and
educational disparities impacting these
diverse communities.
During the COVID–19 pandemic,
tragic acts of anti-Asian violence
increased and cast a shadow of fear and
grief over many AA and NHPI
communities. However, even before the
pandemic, AA and NHPI communities
in the United States have faced
persistent xenophobia, religious
discrimination, racism, and violence.
At the same time, AA and NHPI
communities were overrepresented in
the pandemic’s essential workforce in
healthcare, food supply, education, and
childcare, with more than four million
AA and NHPIs manning the frontlines.
Many AA and NHPI workers, families,
and small businesses also faced
devastating economic losses during this
time.
VerDate Sep<11>2014
20:21 Oct 03, 2023
Jkt 262001
Additionally, health and economic
inequities faced by Native Hawaiian and
Pacific Islander communities worsened
during the COVID–19 pandemic, with
evidence suggesting they were twice as
likely to die from the disease compared
to white counterparts.
The challenges AA and NHPI
communities face are often exacerbated
by a lack of adequate data
disaggregation and language access. The
President’s Advisory Commission on
Asian Americans, Native Hawaiians,
and Pacific Islanders works to advise
the President on executive branch
efforts to address these challenges and
advance equity, justice, and opportunity
for AA and NHPI communities.
Public Participation at Meeting:
Members of the public may attend
virtually. Registration is required
through the following link: https://
www.eventbrite.com/e/meeting-of-thepresidents-advisory-commission-on-aaand-nhpis-tickets-715434733547?aff=
oddtdtcreator.
Written public comments: Written
comments are welcomed throughout the
development of the Commission’s
recommendations to promote equity,
justice, and opportunity for Asian
Americans, Native Hawaiians, and
Pacific Islanders and may be emailed to
AANHPICommission@hhs.gov at any
time. Respond concisely and in plain
language. You may use any structure or
layout that presents your information
well. You may include links to online
material or interactive presentations.
Clearly mark any proprietary
information and place it in its own
section or file. Your response will
become Government property, and we
may publish some of its non-proprietary
content.
Authority: Executive Order 14031.
The President’s Advisory Commission
on Asian Americans, Native Hawaiians,
and Pacific Islanders (Commission) is
governed by provisions of the Federal
Advisory Committee Act (FACA), Public
Law 92–463, as amended (5 U.S.C.
App.), which sets forth standards for the
formation and use of Federal advisory
committees.
Krystal Ka’ai,
Executive Director, White House Initiative on
Asian Americans, Native Hawaiians, and
Pacific Islanders, President’s Advisory
Commission on Asian Americans, Native
Hawaiians, and Pacific Islanders.
[FR Doc. 2023–21981 Filed 10–3–23; 8:45 am]
BILLING CODE 4150–03–P
PO 00000
Frm 00072
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Indian Health Service
Special Diabetes Program for Indians
Announcement Type: New.
Funding Announcement Number:
HHS–2024–IHS–SDPI–0001.
Assistance Listing (Catalog of Federal
Domestic Assistance or CFDA) Number:
93.237.
Key Dates
Application Deadline Date: November
29, 2023.
Earliest Anticipated Start Date:
January 1, 2024.
I. Funding Opportunity Description
Statutory Authority
The Indian Health Service (IHS) is
accepting applications for the Special
Diabetes Program for Indians (SDPI—
formerly Community-Directed SDPI).
This program is authorized under the
Snyder Act, 25 U.S.C. 13; the Transfer
Act, 42 U.S.C. 2001(a); and Section
330C of the Public Health Service Act,
codified at 42 U.S.C. 254c–3. The
Assistance Listings section of SAM.gov
(https://sam.gov/content/home)
describes this program under 93.237.
Background
Diabetes is a complex and costly
chronic disease that requires
tremendous long-term efforts to prevent
and treat. Although diabetes is a
nationwide public health problem,
American Indian/Alaska Native (AI/AN)
people are disproportionately affected.
In 2019, 14.5 percent of AI/AN people
aged 18 years or older had diagnosed
diabetes, compared to 7.4 percent of
non-Hispanic white people [CDC, 2021.
https://www.cdc.gov/diabetes/data/
statistics-report/diagnoseddiabetes.html]. In addition, AI/AN
people have higher rates of diabetesrelated morbidity and mortality than the
general U.S. population [O’Connell,
2010 (https://diabetesjournals.org/care/
article/33/7/1463/39326/RacialDisparities-in-Health-StatusAcomparison-of); Cho, 2014 (https://
ajph.aphapublications.org/doi/full/
10.2105/AJPH.2014.301968)]. Strategies
to address the prevention and treatment
of diabetes in AI/AN communities are
urgently needed.
In response to the burgeoning diabetes
epidemic among AI/AN people,
Congress established the SDPI through
the Balanced Budget Act of 1997. SDPI
is a $150 million per year program that
provides awards for diabetes treatment
and prevention services. The IHS
E:\FR\FM\04OCN1.SGM
04OCN1
Federal Register / Vol. 88, No. 191 / Wednesday, October 4, 2023 / Notices
administers SDPI, with programmatic
oversight provided by the IHS Division
of Diabetes Treatment and Prevention
(DDTP).
Anticipated Number of Awards
Purpose
Period of Performance
The purpose of this program is to
provide diabetes treatment and/or
prevention activities and/or services
(also referred to as ‘‘activities/services’’)
for AI/AN communities. Recipients will
implement one SDPI Diabetes Best
Practice (also referred to as ‘‘Best
Practice’’) and report data on the Best
Practice’s Required Key Measure (RKM).
Recipients may also implement other
activities/services based on diabetesrelated community needs and develop
an evaluation plan. Activities/services
will be aimed at reducing the risk of
diabetes in at-risk individuals,
providing high quality care to those
with diagnosed diabetes, and/or
reducing the complications of diabetes.
The period of performance is for 4
years.
II. Award Information
1. Award Requirements
Funding Instrument—Cooperative
Agreement
a. Create and maintain Best Practices:
focused areas for improvement of
diabetes prevention and treatment
outcomes in communities and clinics.
b. Annual Progress Report: Create and
provide instructions and template(s).
lotter on DSK11XQN23PROD with NOTICES1
Estimated Funds Available
The total funding identified for this
announcement’s period of performance
is approximately $40 million, with the
IHS awarding approximately $10
million each budget year, starting with
fiscal year (FY) 2024. Individual award
amounts for the first budget year are
anticipated to be between $25,000 and
$600,000.
The funding formula, which
determines the funds available to each
IHS area, has been determined through
Tribal consultation. Within each area,
recipient Tribes provide input on the
formula, which determines the amount
of funding available for each successful
applicant.
• Previously awarded SDPI recipients
applying to this announcement should
budget for the same amount as they
received in previous years. However,
funding amounts may change. See the
paragraph below for additional
information.
• New SDPI award applicants should
apply for a $25,000 base amount.
However, funding amounts may change
based on each specific Area’s funding
formula. See the paragraph above.
The funding available for competing
and subsequent continuation awards
issued under this announcement is
subject to the availability of
appropriations and budgetary priorities
of the Agency. The IHS is under no
obligation to make awards to applicants
selected for funding under this
announcement.
VerDate Sep<11>2014
20:21 Oct 03, 2023
Jkt 262001
Approximately 7–20 awards will be
issued under this program
announcement.
Cooperative Agreement
Cooperative agreements awarded by
the Department of Health and Human
Services (HHS) are administered under
the same policies as grants. However,
the funding agency, IHS, is anticipated
to have substantial programmatic
involvement in the project during the
entire period of performance. Below is
a detailed description of the level of
involvement required of the IHS.
Substantial Agency Involvement
Description for Cooperative Agreement
A. DDTP will provide programmatic
oversight, including:
2. Data Collection and Analysis
a. IHS Diabetes Care and Outcomes
Audit: Provide resources, tools, support,
and training.
b. SDPI Outcomes System (SOS):
Create and provide resources, tools,
support, and training. Recipients will
use the SOS to track and report on RKM
data for their selected Best Practice.
3. Training, Communication, and
Technical Assistance
a. Provide extensive SDPI awardrelated trainings: Topics include
Application, Annual Progress Report,
and others. Most trainings are provided
via live webinars. Webinars will be
recorded and made available on the
SDPI website based on importance.
b. Provide updates and
announcements via email.
c. Maintain and update the IHS SDPI
website (https://www.ihs.gov/sdpi/),
which provides information and
resources regarding this cooperative
agreement, including:
i. Best Practices.
ii. Additional resources—Documents
and links from DDTP and the Division
of Grants Management (DGM).
iii. New to SDPI—Information for new
recipients and/or staff.
4. Diabetes Trainings and Resources
a. Provide diabetes-related live,
recorded, and online education
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
68631
developed by the DDTP, designed for
clinicians and other health professionals
serving in the Indian health system.
b. Provide clinical updates and
announcements via email.
c. Maintain and update the DDTP
website, which provides additional
resources for recipients including:
i. Clinician resources—online
continuing education opportunities,
diabetes treatment algorithms, IHS
Standards of Care and Clinical Practice
Recommendations for Type 2 Diabetes,
and IHS Diabetes Care and Outcomes
Audit resources.
ii. Patient education resources—free
materials that can be ordered, printed,
or downloaded from the online catalog.
B. The Indian Health Care
Improvement Act, amended in 1987,
established that each of the 12 IHS
Areas should have an Area Diabetes
Consultant (ADC). The ADCs are health
care professionals with expertise in
diabetes. They play a critical role in
supporting SDPI diabetes treatment and
prevention activities for their Area
including:
1. Oversee SDPI awards within their
specified Area to ensure compliance
with programmatic Terms and
Conditions.
2. Serve as a liaison between the SDPI
award programs, DDTP, and DGM.
3. Provide training and resources to
SDPI recipients. Some resources may be
in the form of additional staff serving as
ADC support.
4. Review or assign a designee to
review annual continuation
applications.
5. May serve as the Program Officer
for the SDPI award programs in their
IHS Area. The Program Officer is a
Federal staff person who is responsible
for managing and monitoring the
progress of recipients in GrantSolutions.
If the ADC is not eligible (i.e., not
Federal program staff), another
individual may serve as the Program
Officer in a limited capacity. Program
Officer’s duties include: creating
funding commitments and memos,
providing programmatic review/
approval of amendments, and assisting
in uploading documents and
information as Grant Notes in
GrantSolutions.
Required, Optional, and Allowable
Activities
Required
All recipients will need to meet the
following requirements:
1. Activities/Services: Recipients must
provide activities/services that:
a. meet the purpose of the SDPI,
which is to provide diabetes treatment
E:\FR\FM\04OCN1.SGM
04OCN1
lotter on DSK11XQN23PROD with NOTICES1
68632
Federal Register / Vol. 88, No. 191 / Wednesday, October 4, 2023 / Notices
and/or prevention services and
activities for AI/AN communities;
b. are targeted at reducing risk factors
for diabetes and diabetes-related
conditions;
c. address diabetes-related issues as
identified in the recipient’s application;
and
d. use SDPI funds as outlined in the
recipient’s Budget Narrative.
2. IHS Diabetes Care and Outcomes
Audit (Diabetes Audit): SDPI recipients
are required to participate in the Annual
Diabetes Audit (https://www.ihs.gov/
diabetes/audit/). Recipients will submit
data, review results, and provide a copy
of their Annual Diabetes Audit Report
with their Continuation Applications.
Non-clinical or community-based
awardees that are not able to directly
participate in the Diabetes Audit, will
need to obtain a copy of the Annual
Diabetes Audit Report from their local
facility or Area Diabetes Consultant
(https://www.ihs.gov/diabetes/about-us/
area-diabetes-consultants-adc/).
3. Best Practices: The Best Practices
(https://www.ihs.gov/sdpi/sdpicommunity-directed/diabetes-bestpractices/) include the latest scientific
findings and recommendations.
Recipients must select one Best Practice
and implement activities/services aimed
at improving the associated RKM.
Recipients will report on RKM data via
the SOS.
4. Collaboration: Recipients must:
a. Consult with and accept guidance
from DDTP, DGM, and their ADC/ADC
Support/Federal Program Officer(s) and/
or designated assignee(s).
b. Respond promptly to requests for
information.
c. Attend required meetings and
trainings.
d. Provide short presentations on their
processes and successes, as requested.
e. Keep the entities (see item a. above)
informed of emerging issues,
developments, and challenges that may
affect the recipient’s ability to comply
with the award Terms and Conditions
and/or any requirements.
5. Project Director: Recipients must
have an officially approved Project
Director (approved by the Grants
Management Officer in consultation
with the Program Official) who has the
following qualifications:
a. Relevant health or wellness
education and/or experience.
b. Experience with award program
management, including skills in
program coordination, budgeting,
reporting, and staff supervision.
c. Working knowledge of diabetes.
The Project Director should routinely
update relevant SDPI award program
staff with information and requirements
VerDate Sep<11>2014
20:21 Oct 03, 2023
Jkt 262001
regarding their program’s activities/
services.
6. Annual Progress Report: Per DGM
policy, the recipient must complete an
annual progress report and submit it
within 90 days of the end of the budget
period. The recipient will submit the
report by uploading it into a Grant Note
in GrantSolutions. DDTP will post
instructions, template(s), and other
information on the SDPI Application/
Report website (https://www.ihs.gov/
sdpi/sdpi-community-directed/
application-reports/).
7. Required Trainings: Recipients
must participate in SDPI required
trainings provided by DDTP. These will
primarily be live webinars, which will
be recorded and posted on the SDPI
website for those not able to attend.
Recipients will be expected to keep
track of participation (both live and
recorded webinars). Information about
the SDPI awardee training requirements
will be provided on the SDPI Grant
Training website (https://www.ihs.gov/
sdpi/sdpi-community-directed/sdpigrant-training/).
Optional
1. Optional Trainings: In addition to
required training, DDTP also provides
optional trainings. Recipients may
participate in SDPI optional trainings
depending on their need for the
information that will be presented.
These will primarily be live webinars,
which will be recorded and posted on
the SDPI website for those not able to
attend. Recipients are not expected to
keep track of participation, but a
training tracking tool is made available
and updated regularly, providing all
required and optional trainings hosted
by DDTP for the year. Information about
the SDPI recipient training requirements
will be provided on the SDPI Grant
Training website (https://www.ihs.gov/
sdpi/sdpi-community-directed/sdpigrant-training/).
2. Diabetes in Indian Country
Conference: DDTP occasionally hosts a
conference that provides continuing
education opportunities and
collaboration on issues related to
improving outcomes for people with
diabetes and those at risk for developing
diabetes. SDPI award training sessions
are provided during this conference.
SDPI recipient attendance is encouraged
but not required.
Allowable
1. Allowable Activities/Services:
There are many types of activities/
services allowed under this award as
long as they meet the activities/services
requirement (see Required.1. above) and
are within the scope of work defined in
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
the Project Narrative. For questions,
contact DDTP.
III. Eligibility Information
1. Eligibility
To be eligible for this FY 2024
funding opportunity, applicants must be
one of the following as required by 42
U.S.C. 254c–3(b):
• An Indian health program operated
by an Indian Tribe or Tribal
organization pursuant to a contract,
grant, cooperative agreement, or
compact with the Indian Health Service
pursuant to the Indian SelfDetermination and Education
Assistance Act [25 U.S.C. 5321 et seq.].
• An urban Indian health program
operated by an urban Indian
Organization pursuant to a grant or
contract with the Indian Health Service
pursuant to title V of the Indian Health
Care Improvement Act [25 U.S.C. 1651
et seq.].
• The Indian Health Service. Under
this announcement, only one SDPI grant
will be awarded per entity. If a Tribe
submits an application or already has an
SDPI grant, their local IHS facility
cannot apply; if the Tribe does not
submit an application or does not
already have an SDPI grant, the IHS
facility can apply. Tribes that are
awarded grant funds may sub-contract
with local IHS facilities to provide
specific clinical services. In this case,
the Tribe would be the primary SDPI
grantee and the Federal entity would
have a sub-contract within the Tribe’s
SDPI grant.
• Not a current SDPI grant recipient.
The Division of Grants Management
(DGM) will notify any applicants
deemed ineligible.
2. Additional Information on Eligibility
The IHS does not fund concurrent
projects. If an applicant is successful
under this announcement, any
subsequent applications in response to
other SDPI announcements from the
same applicant will not be funded.
Applications on behalf of individuals
(including sole proprietorships) and
foreign organizations are not eligible.
Applications deemed ineligible will be
disqualified from competitive review
and funding under this funding
opportunity.
Note: Please refer to Section IV.2
(Application and Submission Information/
Subsection 2, Content and Form of
Application Submission) for additional proof
of applicant status documents required, such
as Tribal Resolutions, proof of nonprofit
status, etc.
E:\FR\FM\04OCN1.SGM
04OCN1
Federal Register / Vol. 88, No. 191 / Wednesday, October 4, 2023 / Notices
3. Cost Sharing or Matching
The IHS does not require matching
funds or cost sharing for grants or
cooperative agreements.
4. Other Requirements
Applications with budget requests
that exceed the highest dollar amount
outlined under Section II Award
Information, Estimated Funds Available,
or exceed the period of performance
outlined under Section II Award
Information, Period of Performance, are
considered not responsive and will not
be reviewed. The DGM will notify the
applicant.
Additional Required Documentation
Tribes and Tribal Organizations
Tribal Resolution
The DGM must receive an official,
signed Tribal Resolution prior to issuing
a Notice of Award (NoA) to any Tribe
or Tribal organization selected for
funding. An applicant that is proposing
a project affecting another Indian Tribe
must include resolutions from all
affected Tribes to be served. However, if
an official signed Tribal Resolution
cannot be submitted with the
application prior to the application
deadline date, a draft Tribal Resolution
must be submitted with the application
by the deadline date in order for the
application to be considered complete
and eligible for review. The draft Tribal
Resolution is not in lieu of the required
signed resolution, but is acceptable until
a signed resolution is received. If an
application without a signed Tribal
Resolution is selected for funding, the
applicant will be contacted by the
Grants Management Specialist (GMS)
listed in this funding announcement
and given 90 days to submit an official,
signed Tribal Resolution to the GMS. If
the signed Tribal Resolution is not
received within 90 days, the award will
be forfeited.
Applicants organized with a
governing structure other than a Tribal
council may submit an equivalent
document commensurate with their
governing organization.
lotter on DSK11XQN23PROD with NOTICES1
Proof of Nonprofit Status
Organizations claiming nonprofit
status must submit a current copy of the
501(c)(3) Certificate with the
application.
IV. Application and Submission
Information
Grants.gov uses a Workspace model
for accepting applications. The
Workspace consists of several online
forms and three forms in which to
upload documents—Project Narrative,
VerDate Sep<11>2014
20:21 Oct 03, 2023
Jkt 262001
Budget Narrative, and Other Documents.
Give your files brief descriptive names.
The filenames are key in finding
specific documents during the objective
review and in processing awards.
Upload all requested and optional
documents individually, rather than
combining them into a package.
Creating a package creates confusion
when trying to find specific documents.
Such confusion can contribute to delays
in processing awards, and could lead to
lower scores during the objective
review.
1. Obtaining Application Materials
The application package and detailed
instructions for this announcement are
available at https://www.Grants.gov.
Please direct questions regarding the
application process to DGM@ihs.gov.
2. Content and Form Application
Submission
Mandatory documents for all
applications are listed below. An
application is incomplete if any of the
listed mandatory documents are
missing. Incomplete applications will
not be reviewed.
• Application forms:
1. SF–424, Application for Federal
Assistance.
2. SF–424A, Budget Information—
Non-Construction Programs.
3. SF–424B, Assurances—NonConstruction Programs.
4. Project Abstract Summary Form.
• Project Narrative (not to exceed 18
pages). See Section IV.2.A, Project
Narrative for more information.
• Budget Justification and Narrative
(not to exceed seven pages). See Section
IV.2.B, Budget Narrative for
instructions.
• One-page Timeframe Chart.
• 2022 and 2023 Annual Diabetes
Audit reports (DRAFT report for 2023 is
acceptable) or copies of Audit waivers
provided by DDTP.
• Letter(s) of Support from one or
more of the following:
1. Board of Directors (Urban Indian
health programs).
2. Chief Executive Officer (IHS
facilities).
3. Tribes served (highly recommended
for IHS facilities).
• Biographical sketches for all Key
Personnel.
• Key contacts form for diabetes
program coordinator.
• Certification Regarding Lobbying
(GG-Lobbying Form).
The documents listed here may be
required. Please read this list carefully.
• Tribal Resolution(s) as described in
Section III, Eligibility.
• 501(c)(3) Certificate.
PO 00000
Frm 00075
Fmt 4703
Sfmt 4703
68633
• Disclosure of Lobbying Activities
(SF–LLL), if applicant conducts
reportable lobbying.
• Copy of current Negotiated Indirect
Cost (IDC) rate agreement (required in
order to receive IDC).
• Contractor/Consultant resumes or
qualifications and scope of work.
• Documentation of current Office of
Management and Budget (OMB)
Financial Audit (if applicable).
Acceptable forms of documentation
include:
1. Email confirmation from Federal
Audit Clearinghouse (FAC) that audits
were submitted; or
2. Face sheets from audit reports.
Applicants can find these on the FAC
website at https://facdissem.census
.gov/.
Additional documents can be
uploaded as Other Attachments in
Grants.gov. These can include:
• Work plan, logic model, and/or
timeline for proposed objectives.
• Position descriptions for key staff.
• Resumes of key staff that reflect
current duties.
• Organizational chart.
• Map of area identifying project
location(s).
• Additional documents to support
narrative (for example, data tables, and
key news articles).
Public Policy Requirements
All Federal public policies apply to
IHS grants and cooperative agreements.
Pursuant to 45 CFR 80.3(d), an
individual shall not be deemed
subjected to discrimination by reason of
their exclusion from benefits limited by
Federal law to individuals eligible for
benefits and services from the IHS. See
https://www.hhs.gov/grants/grants/
grants-policies-regulations/.
Requirements for Project and Budget
Narratives and Other Programmatic
Reports
A. Project Narrative
This narrative should be a separate
document that is no more than 18 pages
and must: (1) have consecutively
numbered pages; (2) use black font 12
points or larger (applicants may use 10point font for tables); (3) be singlespaced; and (4) be formatted to fit
standard letter paper (81⁄2 x 11 inches).
DDTP provides an optional PDF
template on the SDPI Application
website at https://www.ihs.gov/sdpi/
sdpi-community-directed/applicationreports/, which applicants can use to
provide the required information
instead of developing their own format.
Be sure to succinctly answer all
questions listed under the evaluation
E:\FR\FM\04OCN1.SGM
04OCN1
68634
Federal Register / Vol. 88, No. 191 / Wednesday, October 4, 2023 / Notices
criteria (refer to Section V.1, Evaluation
Criteria), and place all responses and
required information in the correct
section noted below or they will not be
considered or scored. If the narrative
exceeds the overall page limit, the
reviewers will be directed to ignore any
content beyond the page limit. The 18page limit for the project narrative does
not include the work plan, standard
forms, Tribal Resolutions, budget,
budget narratives, and/or other items.
Page limits for each section within the
project narrative are guidelines, not
hard limits.
There are six parts to the Project
Narrative:
Part A: Program Identifiers/Experience
(Limit—2 pages)
Information to identify your program
including past experience with diabetes
treatment and preventions in the AI/AN
Communities (include years of
experience), geographic location, food
resources, and relationship or role with
local Indian health clinic.
List current active partnerships
related to your SDPI program and
describe any new partnerships and
collaborations that your SDPI program is
planning to implement. Include
information about how these partners
and collaborators will contribute to the
activities/services you plan to provide.
Part D: SDPI Diabetes Best Practice
(Limit—3 pages)
Section 1: Best Practice Selection
Applicants must select one Best
Practice that addresses one of the needs
that was identified in the needs
assessment (Part B). There is a list of all
the Best Practices on the Best Practices
website: https://www.ihs.gov/sdpi/sdpicommunity-directed/diabetes-bestpractices/. For each Best Practice, there
is a brief statement on the importance,
RKM information, and guidance for
selecting a Target Group, and tools and
resources.
Section 2: Best Practice Activities
Part B: Needs Assessment (Limit—3
pages)
Assessment—identify key diabetesrelated health issues and diabetes
prevalence.
Provide a list of activity(ies)/service(s)
to implement that would improve the
RKM of the selected Best Practice. Each
activity/service should include a brief
description and a timeline for
implementation.
Section 2: Review of Diabetes Audit
Reports
Section 3: Target Group Number and
Description
Obtain and review of 2022 and 2023
Annual Diabetes Audit Reports, to
provide 2–3 items/elements that need to
be improved and how your program will
address those items/elements.
Recipients will be required to report
RKM data for one Target Group for their
selected Best Practice. A Target Group is
the largest number of patients/
participants that you can realistically
include in the activities/services you
provided in the Best Practice activities
for the budget period. The following
should be considered in selecting your
Target Group:
a. The size and characteristics (e.g.,
ages, health status, settings, locations) of
the community or patient population
that you are going to draw your Target
Group from;
b. Intensity of the activities/services
you plan to do;
c. and SDPI funding and other
resources available to provide activities/
services.
Section 1: Diabetes Needs
Section 3: Challenges
Identify and describe challenges your
program experiences or may face related
to prevention and/or treatment of
diabetes.
Part C: Program Support and Resources
(Limit—3 pages)
Section 1: Leadership Support
Identify at least one organization
administrator or Tribal leaders (other
than your Program Coordinator) who
has agreed to support your SDPI
program for 2024 and describe how they
will be actively involved with your
program.
lotter on DSK11XQN23PROD with NOTICES1
Section 3: Partnerships and
Collaborations
Section 2: Key Personnel
List all key personnel that will be
involved in your program’s activities/
services. This may be your ‘‘Diabetes
Team.’’ You must also separately
provide a brief resume or biographical
sketch for all key personnel listed.
VerDate Sep<11>2014
20:21 Oct 03, 2023
Jkt 262001
Part E: Activities/Services not related to
selected Best Practice (Optional. Limit—
5 pages)
Provide information for up to five
major activities/services, supported by
SDPI funds, to address needs that were
identified in the needs assessment (Part
B). Activities/services reported here
should be based on the following
criteria:
PO 00000
Frm 00076
Fmt 4703
Sfmt 4703
a. Use the most award funding and
program time.
b. Address significant needs/
challenges.
Part F: Additional Information (Limit—
2 pages)
Provide additional information as
specified by program office.
B. Budget Narrative (Limit—7 pages)
Provide a budget narrative that
explains the amounts requested for each
line item of the budget from the SF–
424A (Budget Information for NonConstruction Programs) for the first year
of the project. The applicant can submit
with the budget narrative a more
detailed spreadsheet than is provided by
the SF–424A (the spreadsheet will not
be considered part of the budget
narrative). The budget narrative should
specifically describe how each item will
support the achievement of proposed
objectives. Be very careful about
showing how each item in the ‘‘Other’’
category is justified. For subsequent
budget years (see Multi-Year Project
Requirements in Section V.1,
Application Review Information,
Evaluation Criteria), the additional
pages should highlight the changes from
the first year or clearly indicate that
there are no substantive budget changes
during the period of performance. Do
NOT use the budget narrative to expand
the project narrative.
C. IHS Diabetes Care and Outcomes
Audit
The IHS Diabetes Care and Outcomes
Audit is a process to assess care and
health outcomes for AI/AN people with
diagnosed diabetes. IHS, Tribal, and
Urban Indian health care facilities
nationwide participate in this process
each year by auditing medical records
for their patients with diabetes.
Applicants who are able to must submit
copies of their local facility’s 2022 and
2023 Annual Diabetes Audit reports or
copies of the Audit waivers provided by
DDTP.
Annual Diabetes Audit reports can be
obtained in the following ways:
a. Via the WebAudit: https://
www.ihs.gov/diabetes/audit/.
b. Request from their local facility.
c. Request from their ADC: https://
www.ihs.gov/diabetes/about-us/areadiabetes-consultants-adc/.
For programs that received Audit
waivers, these can be found in
GrantSolutions (as a Grant Note).
If the applicant is unable to obtain
their local facility’s 2022 and 2023
Annual Diabetes Audit Reports, they
must provide an explanation in their
E:\FR\FM\04OCN1.SGM
04OCN1
Federal Register / Vol. 88, No. 191 / Wednesday, October 4, 2023 / Notices
Project Narrative (Part B). For any
questions, contact DDTP.
3. Submission Dates and Times
Applications must be submitted
through Grants.gov by 11:59 p.m.
Eastern Time on the Application
Deadline Date. Any application received
after the application deadline will not
be accepted for review. Grants.gov will
notify the applicant via email if the
application is rejected.
If technical challenges arise and
assistance is required with the
application process, contact Grants.gov
Customer Support (see contact
information at https://www.Grants.gov).
If problems persist, contact Mr. Paul
Gettys, Deputy Director, DGM, by email
at DGM@ihs.gov. Please be sure to
contact Mr. Gettys at least 10 days prior
to the application deadline. Please do
not contact the DGM until you have
received a Grants.gov tracking number.
In the event you are not able to obtain
a tracking number, call the DGM as soon
as possible by email at DGM@ihs.gov.
The IHS will not acknowledge receipt
of applications.
4. Intergovernmental Review
Executive Order 12372 requiring
intergovernmental review is not
applicable to this program.
5. Funding Restrictions
• Pre-award costs are allowable up to
90 days before the start date of the
award provided the costs are otherwise
allowable if awarded. Pre-award costs
are incurred at the risk of the applicant.
• The available funds are inclusive of
direct and indirect costs.
• Only one cooperative agreement
will be awarded per applicant.
lotter on DSK11XQN23PROD with NOTICES1
6. Electronic Submission Requirements
All applications must be submitted
via Grants.gov. Please use the https://
www.Grants.gov website to submit an
application. Find the application by
selecting the ‘‘Search Grants’’ link on
the homepage. Follow the instructions
for submitting an application under the
Package tab. No other method of
application submission is acceptable.
If you cannot submit an application
through Grants.gov, you must request a
waiver prior to the application due date.
You must submit your waiver request by
email to DGM@ihs.gov. Your waiver
request must include clear justification
for the need to deviate from the required
application submission process. The
IHS will not accept any applications
submitted through any means outside of
Grants.gov without an approved waiver.
If the DGM approves your waiver
request, you will receive a confirmation
VerDate Sep<11>2014
20:21 Oct 03, 2023
Jkt 262001
of approval email containing
submission instructions. You must
include a copy of the written approval
with the application submitted to the
DGM. Applications that do not include
a copy of the waiver approval from the
DGM will not be reviewed. The Grants
Management Officer of the DGM will
notify the applicant via email of this
decision. Applications submitted under
waiver must be received by the DGM no
later than 5:00 p.m. Eastern Time on the
Application Deadline Date. Late
applications will not be accepted for
processing. Applicants that do not
register for both the System for Award
Management (SAM) and Grants.gov
and/or fail to request timely assistance
with technical issues will not be
considered for a waiver to submit an
application via alternative method.
Please be aware of the following:
• Please search for the application
package in https://www.Grants.gov by
entering the Assistance Listing number
or the Funding Opportunity Number.
Both numbers are located in the header
of this announcement.
• If you experience technical
challenges while submitting your
application, please contact Grants.gov
Customer Support (see contact
information at https://www.Grants.gov).
• Upon contacting Grants.gov, obtain
a tracking number as proof of contact.
The tracking number is helpful if there
are technical issues that cannot be
resolved and a waiver from the agency
must be obtained.
• Applicants are strongly encouraged
not to wait until the deadline date to
begin the application process through
Grants.gov as the registration process for
SAM and Grants.gov could take up to 20
working days.
• Please follow the instructions on
Grants.gov to include additional
documentation that may be requested by
this funding announcement.
• Applicants must comply with any
page limits described in this funding
announcement.
• After submitting the application,
you will receive an automatic
acknowledgment from Grants.gov that
contains a Grants.gov tracking number.
The IHS will not notify you that the
application has been received.
System for Award Management
Organizations that are not registered
with the System for Award Management
(SAM) must access the SAM online
registration through the SAM home page
at https://sam.gov. Organizations based
in the United States (U.S.) will also
need to provide an Employer
Identification Number from the Internal
Revenue Service that may take an
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
68635
additional 2–5 weeks to become active.
Please see SAM.gov for details on the
registration process and timeline.
Registration with the SAM is free of
charge but can take several weeks to
process. Applicants may register online
at https://sam.gov.
Unique Entity Identifier
Your SAM.gov registration now
includes a Unique Entity Identifier
(UEI), generated by SAM.gov, which
replaces the DUNS number obtained
from Dun and Bradstreet. SAM.gov
registration no longer requires a DUNS
number.
Check your organization’s SAM.gov
registration as soon as you decide to
apply for this program. If your SAM.gov
registration is expired, you will not be
able to submit an application. It can take
several weeks to renew it or resolve any
issues with your registration, so do not
wait.
Check your Grants.gov registration.
Registration and role assignments in
Grants.gov are self-serve functions. One
user for your organization will have the
authority to approve role assignments,
and these must be approved for active
users in order to ensure someone in
your organization has the necessary
access to submit an application.
The Federal Funding Accountability
and Transparency Act of 2006, as
amended (‘‘Transparency Act’’),
requires all HHS recipients to report
information on sub-awards.
Accordingly, all IHS recipients must
notify potential first-tier sub-recipients
that no entity may receive a first-tier
sub-award unless the entity has
provided its UEI number to the prime
recipient organization. This requirement
ensures the use of a universal identifier
to enhance the quality of information
available to the public pursuant to the
Transparency Act.
Additional information on
implementing the Transparency Act,
including the specific requirements for
SAM, are available on the DGM Grants
Management, Policy Topics web page at
https://www.ihs.gov/dgm/policytopics/.
V. Application Review Information
Possible points assigned to each
section are noted in parentheses. The
project narrative and budget narrative
should include only the first year of
activities; information for multi-year
projects should be included as a
separate document. See ‘‘Multi-year
Project Requirements’’ at the end of this
section for more information. The
project narrative should be written in a
manner that is clear to outside reviewers
unfamiliar with prior related activities
of the applicant. It should be well
E:\FR\FM\04OCN1.SGM
04OCN1
68636
Federal Register / Vol. 88, No. 191 / Wednesday, October 4, 2023 / Notices
organized, succinct, and contain all
information necessary for reviewers to
fully understand the project.
Attachments requested in the criteria do
not count toward the page limit for the
narratives. Points will be assigned to
each evaluation criteria adding up to a
total of 100 possible points. Points are
assigned as follows:
1. Evaluation Criteria
A. Introduction and Need for Assistance
(15 points)
(i) Program Identifiers/Experience
(Project Narrative Part A)
(1) Was program identifier
information adequately provided?
(2) Did applicant provide sufficient
information to establish their location
and relationship to their local Indian
Health Clinic?
(ii) Needs Assessment (Project Narrative
Part B)
(1) Did the applicant adequately
describe the key diabetes-related health
issues identified by their community/
leadership?
(2) Were numbers provided for
applicant’s local user population and
people with diagnosed diabetes?
(3) Did the applicant appropriately
identify Diabetes Audit items (or
diabetes-related issues if Audit Reports
were not provided) that need to be
improved?
(4) Did the applicant adequately
describe how they will address the
Diabetes Audit items or diabetes-related
issues that need to be improved?
(5) Did the applicant adequately
describe challenges?
B. Project Objective(s), Work Plan and
Approach (30 points)
(i) SDPI Diabetes Best Practice (Project
Narrative Part D)
lotter on DSK11XQN23PROD with NOTICES1
(1) Did the applicant provide an
adequate description of activities/
services to improve the RKM?
(2) Are the activities/services
proposed appropriate for the selected
Best Practice and Target Group?
(3) Do the planned activities/services
appear to be reasonable given the
constraints of timeframe, resources, and
staff?
(ii) If Applicable: Activities/Services
Not Related to Selected Best Practice
(Project Narrative Part E)
(1) Do activities/services address
diabetes-related issues identified in the
needs assessment in Part B?
(2) Are activities/services aimed at
reducing risk factors for diabetes and/or
related conditions?
VerDate Sep<11>2014
20:21 Oct 03, 2023
Jkt 262001
(3) Are activities/services adequately
described?
(4) Do the planned activities/services
appear to be reasonable given the
constraints of timeframe, resources, and
staff?
C. Program Evaluation (15 points)
(i) SDPI Diabetes Best Practice (Project
Narrative Part D)
(1) Was a Best Practice selected?
(2) Was the number of patients/
participants in the Target Group
provided?
(3) Was the Target Group adequately
described?
(4) Are the Target Group and number
of patients/participants reasonable given
the information the applicant provided
in their needs assessment and program
resources sections?
(ii) If Applicable: Activities/Services
Not Related to Selected Best Practice
(Project Narrative Part E)
(1) Was an appropriate target group
identified for each activity/service?
(2) Did the applicant specify how
improvement and reduction in risk
factors will be evaluated?
D. Organizational Capabilities, Key
Personnel, and Qualifications (30
points)
(i) Program Identifiers/Experience
(Project Narrative Part A)
(1) Does the applicant have
experience with diabetes treatment and
prevention services in AI/AN
communities?
(2) Is the experience provided recent?
(within 5 years)
(ii) Program Support (Project Narrative
Part C)
(1) Does the program propose to
provide sufficient and appropriate staff
to carry out planned activities?
(2) Did the applicant identify an
appropriate organization administrator
or Tribal leader, other than the Program
Coordinator, to support their SDPI
program?
(3) Did the applicant describe how
this leader will be involved with the
SDPI program?
(4) Did the applicant provide
appropriate and adequate information
about key personnel in the Project
Narrative?
(5) Did the applicant provide
appropriate and adequate information
about partnerships and collaborations in
the Project Narrative?
E. Categorical Budget and Budget
Justification (10 points)
(i) Does the budget match the scope of
work described in the Project Narrative?
PO 00000
Frm 00078
Fmt 4703
Sfmt 4703
(ii) Was each line item adequately
specified and justified?
(iii) Do funding totals match between
the SF–424A, budget line item, and
justification?
(iv) Is the budget reasonable and
realistic?
Multi-Year Project Requirements
Applications must include a brief
project narrative and budget (one
additional page per year) addressing the
developmental plans for each additional
year of the project. This attachment will
not count as part of the project narrative
or the budget narrative.
2. Review and Selection
Each application will be prescreened
for eligibility and completeness as
outlined in this funding announcement.
The Review Committee (RC) will review
applications that meet the eligibility
criteria. The RC will review the
applications for merit based on the
evaluation criteria. Incomplete
applications and applications that are
not responsive to the administrative
thresholds (budget limit, period of
performance limit) will not be referred
to the RC and will not be funded. The
DGM will notify the applicant of this
determination.
Applicants must address all program
requirements and provide all required
documentation.
3. Notifications of Disposition
All applicants will receive an
Executive Summary Statement from the
IHS DDTP within 30 days of the
conclusion of the review outlining the
strengths and weaknesses of their
application. The summary statement
will be sent to the Authorizing Official
identified on the face page (SF–424) of
the application.
A. Award Notices for Funded
Applications
The NoA is the authorizing document
for which funds are dispersed to the
approved entities and reflects the
amount of Federal funds awarded, the
purpose of the award, the terms and
conditions of the award, the effective
date of the award, the budget period,
and period of performance. Each entity
approved for funding must have a user
account in GrantSolutions in order to
retrieve the NoA. Please see the Agency
Contacts list in Section VII for the
systems contact information.
B. Approved but Unfunded
Applications
Approved applications not funded
due to lack of available funds will be
held for 1 year. If funding becomes
E:\FR\FM\04OCN1.SGM
04OCN1
Federal Register / Vol. 88, No. 191 / Wednesday, October 4, 2023 / Notices
available during the course of the year,
the application may be reconsidered.
Note: Any correspondence other than the
official NoA executed by an IHS grants
management official announcing to the
project director that an award has been made
to their organization is not an authorization
to implement their program on behalf of the
IHS.
VI. Award Administration Information
lotter on DSK11XQN23PROD with NOTICES1
1. Administrative Requirements
Awards issued under this
announcement are subject to, and are
administered in accordance with, the
following regulations and policies:
A. The criteria as outlined in this
program announcement.
B. Administrative Regulations for
Awards:
• Uniform Administrative
Requirements, Cost Principles, and
Audit Requirements for HHS Awards
currently in effect or implemented
during the period of award, other
Department regulations and policies in
effect at the time of award, and
applicable statutory provisions. At the
time of publication, this includes 45
CFR part 75, at https://www.govinfo.gov/
content/pkg/CFR-2022-title45-vol1/pdf/
CFR-2022-title45-vol1-part75.pdf.
• If you receive an award, HHS may
terminate it if any of the conditions in
2 CFR 200.340(a)(1)–(4) are met. Please
review all HHS regulatory provisions for
Termination at 45 CFR 75.372, at the
time of this publication located at
https://www.govinfo.gov/content/pkg/
CFR-2022-title45-vol1/pdf/CFR-2022title45-vol1-sec75-372.pdf.
C. Grants Policy:
• HHS Grants Policy Statement,
Revised January 2007, at https://
www.hhs.gov/sites/default/files/grants/
grants/policies-regulations/
hhsgps107.pdf.
D. Cost Principles:
• Uniform Administrative
Requirements for HHS Awards, ‘‘Cost
Principles,’’ at 45 CFR part 75 subpart
E, at the time of this publication located
at https://www.govinfo.gov/content/pkg/
CFR-2022-title45-vol1/pdf/CFR-2022title45-vol1-part75-subpartE.pdf.
E. Audit Requirements:
• Uniform Administrative
Requirements for HHS Awards, ‘‘Audit
Requirements,’’ at 45 CFR part 75
subpart F, at the time of this publication
located at https://www.govinfo.gov/
content/pkg/CFR-2022-title45-vol1/pdf/
CFR-2022-title45-vol1-part75subpartF.pdf.
F. As of August 13, 2020, 2 CFR part
200 was updated to include a
prohibition on certain
telecommunications and video
VerDate Sep<11>2014
20:21 Oct 03, 2023
Jkt 262001
surveillance services or equipment. This
prohibition is described in 2 CFR
200.216. This will also be described in
the terms and conditions of every IHS
grant and cooperative agreement
awarded on or after August 13, 2020.
2. Indirect Costs
This section applies to all recipients
that request reimbursement of IDC in
their application budget. In accordance
with HHS Grants Policy Statement, Part
II–27, the IHS requires applicants to
obtain a current IDC rate agreement and
submit it to the DGM prior to the DGM
issuing an award. The rate agreement
must be prepared in accordance with
the applicable cost principles and
guidance as provided by the cognizant
agency or office. A current rate covers
the applicable award activities under
the current award’s budget period. If the
current rate agreement is not on file
with the DGM at the time of award, the
IDC portion of the budget will be
restricted. The restrictions remain in
place until the current rate agreement is
provided to the DGM. Per 2 CFR
200.414(f) Indirect (F&A) costs,
any non-Federal entity (NFE) [i.e., applicant]
that does not have a current negotiated rate,
. . . may elect to charge a de minimis rate
of 10 percent of modified total direct costs
which may be used indefinitely. As
described in Section 200.403, costs must be
consistently charged as either indirect or
direct costs, but may not be double charged
or inconsistently charged as both. If chosen,
this methodology once elected must be used
consistently for all Federal awards until such
time as the NFE chooses to negotiate for a
rate, which the NFE may apply to do at any
time.
Electing to charge a de minimis rate
of 10 percent can be used by applicants
that have received an approved
negotiated indirect cost rate from HHS
or another cognizant Federal agency.
Applicants awaiting approval of their
indirect cost proposal may request the
10 percent de minimis rate. When the
applicant chooses this method, costs
included in the indirect cost pool must
not be charged as direct costs to the
award. Available funds are inclusive of
direct and appropriate indirect costs.
Approved indirect funds are awarded as
part of the award amount, and no
additional funds will be provided.
Generally, IDC rates for IHS recipients
are negotiated with the Division of Cost
Allocation at https://rates.psc.gov/ or
the Department of the Interior (Interior
Business Center) at https://ibc.doi.gov/
ICS/tribal. For questions regarding the
indirect cost policy, please write to
DGM@ihs.gov.
PO 00000
Frm 00079
Fmt 4703
Sfmt 4703
68637
3. Reporting Requirements
The recipient must submit required
reports consistent with the applicable
deadlines. Failure to submit required
reports within the time allowed may
result in suspension or termination of
an active award, withholding of
additional awards for the project, or
other enforcement actions such as
withholding of payments or converting
to the reimbursement method of
payment. Continued failure to submit
required reports may result in the
imposition of special award provisions
and/or the non-funding or non-award of
other eligible projects or activities. This
requirement applies whether the
delinquency is attributable to the failure
of the recipient organization or the
individual responsible for preparation
of the reports. Per DGM policy, all
reports must be submitted electronically
by attaching them as a ‘‘Grant Note’’ in
GrantSolutions. Personnel responsible
for submitting reports will be required
to obtain a login and password for
GrantSolutions. Please use the form
under the Recipient User section of
https://www.grantsolutions.gov/home/
getting-started-request-a-user-account/.
Download the Recipient User Account
Request Form, fill it out completely, and
submit it as described on the web page
and in the form.
The reporting requirements for this
program are noted below.
A. Progress Reports
Program progress reports are required
annually. The progress reports are due
within 30 days after the reporting period
ends (specific dates will be listed in the
NoA Terms and Conditions). These
reports must include a brief comparison
of actual accomplishments to the goals
established for the period, a summary of
progress to date or, if applicable,
provide sound justification for the lack
of progress, and other pertinent
information as required. Recipient must
submit a final report within 120 days of
the period of performance end date.
Instructions, template(s), and other
information will be posted on the SDPI
website at https://www.ihs.gov/sdpi/
sdpi-community-directed/applicationreports/.
B. Financial Reports
Federal Financial Reports are due 90
days after the end of each budget period,
and a final report is due 120 days after
the end of the period of performance.
Recipients are responsible and
accountable for reporting accurate
information on all required reports: the
Progress Reports and the Federal
Financial Report.
E:\FR\FM\04OCN1.SGM
04OCN1
68638
Federal Register / Vol. 88, No. 191 / Wednesday, October 4, 2023 / Notices
Failure to submit timely reports may
result in adverse award actions blocking
access to funds.
lotter on DSK11XQN23PROD with NOTICES1
C. Data Collection and Reporting
SOS RKM Data Requirements: Data
for the selected Best Practice RKM will
be submitted using the SOS. Recipients
will submit results for their RKM for
their selected Best Practice into this
system at the start (baseline) and end
(final) of the budget period, with the
option to submit more frequently. The
system will generate SOS RKM data
reports to meet the SDPI outcomes
reporting requirements. These results
will be stored in the system and will be
accessible to program staff, as needed.
Recipients will need to appoint at least
one person in their program to get
access to and submit data into the SOS.
i. Baseline data: Data is to be
submitted into the SOS by the last
business day of February each year (e.g.,
2024 baseline data will be by Thursday,
February 29, 2024). A report from the
SOS showing baseline data submission
will be due with continuation
applications.
ii. Final data: Data for the prior
budget period is to be submitted into the
SOS by the last business day of January,
each year (e.g., 2024 final data will be
due by Friday, January 31, 2025). A
report from the SOS showing baseline
and final data submission will be due
with the Annual Progress Report.
Refer to the SDPI website (https://
www.ihs.gov/sdpi/) for the latest
information on report templates, due
dates, webinars and submission
instructions.
Diabetes Care and Outcomes Audit:
SDPI recipients are required to
participate in the Annual Diabetes
Audit (https://www.ihs.gov/diabetes/
audit/). Recipients will submit data,
review results, and provide a copy of
their Annual Diabetes Audit Report
with their annual SDPI applications.
Diabetes Annual Audit data are to be
submitted into the WebAudit each year
around mid-March, (e.g., 2024 Audit
data collecting annual data will be due
approximately March 15, 2024). Nonclinical or community-based recipients,
that are not able to directly participate
in the Diabetes Audit, will need to
obtain a copy of the Annual Diabetes
Audit Report from their local facility or
Area Diabetes Consultant (https://
www.ihs.gov/diabetes/about-us/areadiabetes-consultants-adc/).
D. Federal Sub-award Reporting System
(FSRS)
This award may be subject to the
Transparency Act sub-award and
VerDate Sep<11>2014
20:21 Oct 03, 2023
Jkt 262001
executive compensation reporting
requirements of 2 CFR part 170.
The Transparency Act requires the
OMB to establish a single searchable
database, accessible to the public, with
information on financial assistance
awards made by Federal agencies. The
Transparency Act also includes a
requirement for recipients of Federal
grants to report information about firsttier sub-awards and executive
compensation under Federal assistance
awards.
The IHS has implemented a Term of
Award into all IHS Standard Terms and
Conditions, NoAs, and funding
announcements regarding the FSRS
reporting requirement. This IHS Term of
Award is applicable to all IHS grant and
cooperative agreements issued on or
after October 1, 2010, with a $25,000
sub-award obligation threshold met for
any specific reporting period.
For the full IHS award term
implementing this requirement and
additional award applicability
information, visit the DGM Grants
Management website at https://
www.ihs.gov/dgm/policytopics/.
E. Non-Discrimination Legal
Requirements for Recipients of Federal
Financial Assistance (FFA)
If you receive an award, you must
follow all applicable nondiscrimination
laws. You agree to this when you
register in SAM.gov. You must also
submit an Assurance of Compliance
(HHS–690). To learn more, see https://
www.hhs.gov/civil-rights/for-providers/
laws-regulations-guidance/laws/
index.html. Pursuant to 45 CFR 80.3(d),
an individual shall not be deemed
subjected to discrimination by reason of
their exclusion from benefits limited by
Federal law to individuals eligible for
benefits and services from the IHS.
F. Federal Awardee Performance and
Integrity Information System (FAPIIS)
The IHS is required to review and
consider any information about the
applicant that is in the FAPIIS at
https://www.fapiis.gov/fapiis/#/home
before making any award in excess of
the simplified acquisition threshold
(currently $250,000) over the period of
performance. An applicant may review
and comment on any information about
itself that a Federal awarding agency
previously entered. The IHS will
consider any comments by the
applicant, in addition to other
information in FAPIIS, in making a
judgment about the applicant’s integrity,
business ethics, and record of
performance under Federal awards
when completing the review of risk
PO 00000
Frm 00080
Fmt 4703
Sfmt 4703
posed by applicants, as described in 45
CFR 75.205.
As required by 45 CFR part 75
Appendix XII of the Uniform Guidance,
NFEs are required to disclose in FAPIIS
any information about criminal, civil,
and administrative proceedings, and/or
affirm that there is no new information
to provide. This applies to NFEs that
receive Federal awards (currently active
grants, cooperative agreements, and
procurement contracts) greater than $10
million for any period of time during
the period of performance of an award/
project.
Mandatory Disclosure Requirements
As required by 2 CFR part 200 of the
Uniform Guidance, and the HHS
implementing regulations at 45 CFR part
75, the IHS must require an NFE or an
applicant for a Federal award to
disclose, in a timely manner, in writing
to the IHS or pass-through entity all
violations of Federal criminal law
involving fraud, bribery, or gratuity
violations potentially affecting the
Federal award.
All applicants and recipients must
disclose in writing, in a timely manner,
to the IHS and to the HHS Office of
Inspector General all information
related to violations of Federal criminal
law involving fraud, bribery, or gratuity
violations potentially affecting the
Federal award. 45 CFR 75.113.
Disclosures must be sent in writing to:
U.S. Department of Health and Human
Services Indian Health Service,
Division of Grants Management,
ATTN: Marsha Brookins, Director,
5600 Fishers Lane, Mail Stop: 09E70,
Rockville, MD 20857, (Include
‘‘Mandatory Grant Disclosures’’ in
subject line), Office: (301) 443–4750,
Fax: (301) 594–0899, Email: DGM@
ihs.gov
AND
U.S. Department of Health and Human
Services, Office of Inspector General,
ATTN: Mandatory Grant Disclosures,
Intake Coordinator, 330 Independence
Avenue SW, Cohen Building, Room
5527, Washington, DC 20201, URL:
https://oig.hhs.gov/fraud/reportfraud/, (Include ‘‘Mandatory Grant
Disclosures’’ in subject line), Fax:
(202) 205–0604 (Include ‘‘Mandatory
Grant Disclosures’’ in subject line) or
Email:
MandatoryGranteeDisclosures@
oig.hhs.gov
Failure to make required disclosures
can result in any of the remedies
described in 45 CFR 75.371 Remedies
for noncompliance, including
suspension or debarment (see 2 CFR
part 180 and 2 CFR part 376).
E:\FR\FM\04OCN1.SGM
04OCN1
Federal Register / Vol. 88, No. 191 / Wednesday, October 4, 2023 / Notices
VII. Agency Contacts
1. Questions on the programmatic
issues may be directed to:
Applicant’s Area Diabetes Consultant:
https://www.ihs.gov/diabetes/aboutus/area-diabetes-consultants-adc/,
IHS Division of Diabetes Treatment
and Prevention, 5600 Fishers Lane,
Mailstop: 08N34A, Rockville, MD
20857, Phone: (844) 447–3387, Fax:
(301) 594–6213, Email:
diabetesprogram@ihs.gov and sdpi@
ihs.gov, Division of Diabetes website:
https://www.ihs.gov/diabetes/ and
https://www.ihs.gov/sdpi/
2. Questions on awards management
and fiscal matters may be directed to:
Indian Health Service, Division of
Grants Management, 5600 Fishers
Lane, Mail Stop: 09E70, Rockville,
MD 20857, Email: DGM@ihs.gov.
3. For technical assistance with
Grants.gov, please contact the
Grants.gov help desk at (800) 518–4726,
or by email at support@grants.gov.
4. For technical assistance with
GrantSolutions, please contact the
GrantSolutions help desk at (866) 577–
0771, or by email at help@
grantsolutions.gov.
VIII. Other Information
The Public Health Service strongly
encourages all grant, cooperative
agreement, and contract recipients to
provide a smoke-free workplace and
promote the non-use of all tobacco
products. In addition, Public Law 103–
227, the Pro-Children Act of 1994,
prohibits smoking in certain facilities
(or in some cases, any portion of the
facility) in which regular or routine
education, library, day care, health care,
or early childhood development
services are provided to children. This
is consistent with the HHS mission to
protect and advance the physical and
mental health of the American people.
BILLING CODE 4166–14–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
lotter on DSK11XQN23PROD with NOTICES1
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
20:21 Oct 03, 2023
Jkt 262001
Dated: September 28, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–21974 Filed 10–3–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: September 29, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel; High Quality Reference Genomes
(HQRG).
Date: November 29, 2023.
Time: 3:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Human Genome Research
Institute, National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Rudy O. Pozzatti, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Human Genome Research
Institute, National Institutes of Health, 6700B
Rockledge Drive, MSC 6908, Bethesda, MD
20892, (301) 402–8739, pozzattr@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
[FR Doc. 2023–22045 Filed 10–3–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Cancer Institute; Amended
Notice of Meeting
[FR Doc. 2023–22057 Filed 10–3–23; 8:45 am]
partially closed to closed. Due to
scheduling difficulties, there will no
longer be an open session of the
meeting. The meeting is closed to the
public.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Developing Digital Therapeutics for
Substance Use Disorders.
Date: November 14, 2023.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Health,
National Institute on Drug Abuse, 301 North
Stonestreet Avenue, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Jenny Raye Browning,
Ph.D., Scientific Review Officer, Scientific
Review Branch, Division of Extramural
Research, National Institute on Drug Abuse,
NIH, 301 North Stonestreet Avenue, MSC
6021, Bethesda, MD 20892, (301) 443–4577,
jenny.browning@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist
Development Awards, and Research Scientist
Awards; 93.278, Drug Abuse National
Research Service Awards for Research
Training; 93.279, Drug Abuse and Addiction
Research Programs, National Institutes of
Health, HHS)
National Institutes of Health
Roselyn Tso,
Director, Indian Health Service.
VerDate Sep<11>2014
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
68639
Notice is hereby given of a change in
the meeting of the Board of Scientific
Counselors, National Cancer Institute,
November 13, 2023, 10 a.m. to
November 14, 2023, 1:45 p.m., National
Institute of Health, Building 31, C Wing,
6th Floor, Conference Room C, 9000
Rockville Pike, Bethesda, MD 20892,
which was published in the Federal
Register on September 28, 2023, FR Doc
2023–21147, 88 FR 66861.
This meeting notice is being amended
to change the meeting type from
PO 00000
Frm 00081
Fmt 4703
Sfmt 4703
National Institutes of Health
National Human Genome Research
Institute; Notice of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Dated: September 28, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–21889 Filed 10–3–23; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\04OCN1.SGM
04OCN1
Agencies
[Federal Register Volume 88, Number 191 (Wednesday, October 4, 2023)]
[Notices]
[Pages 68630-68639]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-22057]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Indian Health Service
Special Diabetes Program for Indians
Announcement Type: New.
Funding Announcement Number: HHS-2024-IHS-SDPI-0001.
Assistance Listing (Catalog of Federal Domestic Assistance or CFDA)
Number: 93.237.
Key Dates
Application Deadline Date: November 29, 2023.
Earliest Anticipated Start Date: January 1, 2024.
I. Funding Opportunity Description
Statutory Authority
The Indian Health Service (IHS) is accepting applications for the
Special Diabetes Program for Indians (SDPI--formerly Community-Directed
SDPI). This program is authorized under the Snyder Act, 25 U.S.C. 13;
the Transfer Act, 42 U.S.C. 2001(a); and Section 330C of the Public
Health Service Act, codified at 42 U.S.C. 254c-3. The Assistance
Listings section of SAM.gov (https://sam.gov/content/home) describes
this program under 93.237.
Background
Diabetes is a complex and costly chronic disease that requires
tremendous long-term efforts to prevent and treat. Although diabetes is
a nationwide public health problem, American Indian/Alaska Native (AI/
AN) people are disproportionately affected. In 2019, 14.5 percent of
AI/AN people aged 18 years or older had diagnosed diabetes, compared to
7.4 percent of non-Hispanic white people [CDC, 2021. https://www.cdc.gov/diabetes/data/statistics-report/diagnosed-diabetes.html].
In addition, AI/AN people have higher rates of diabetes-related
morbidity and mortality than the general U.S. population [O'Connell,
2010 (https://diabetesjournals.org/care/article/33/7/1463/39326/Racial-Disparities-in-Health-StatusA-comparison-of); Cho, 2014 (https://ajph.aphapublications.org/doi/full/10.2105/AJPH.2014.301968)].
Strategies to address the prevention and treatment of diabetes in AI/AN
communities are urgently needed.
In response to the burgeoning diabetes epidemic among AI/AN people,
Congress established the SDPI through the Balanced Budget Act of 1997.
SDPI is a $150 million per year program that provides awards for
diabetes treatment and prevention services. The IHS
[[Page 68631]]
administers SDPI, with programmatic oversight provided by the IHS
Division of Diabetes Treatment and Prevention (DDTP).
Purpose
The purpose of this program is to provide diabetes treatment and/or
prevention activities and/or services (also referred to as
``activities/services'') for AI/AN communities. Recipients will
implement one SDPI Diabetes Best Practice (also referred to as ``Best
Practice'') and report data on the Best Practice's Required Key Measure
(RKM). Recipients may also implement other activities/services based on
diabetes-related community needs and develop an evaluation plan.
Activities/services will be aimed at reducing the risk of diabetes in
at-risk individuals, providing high quality care to those with
diagnosed diabetes, and/or reducing the complications of diabetes.
II. Award Information
Funding Instrument--Cooperative Agreement
Estimated Funds Available
The total funding identified for this announcement's period of
performance is approximately $40 million, with the IHS awarding
approximately $10 million each budget year, starting with fiscal year
(FY) 2024. Individual award amounts for the first budget year are
anticipated to be between $25,000 and $600,000.
The funding formula, which determines the funds available to each
IHS area, has been determined through Tribal consultation. Within each
area, recipient Tribes provide input on the formula, which determines
the amount of funding available for each successful applicant.
Previously awarded SDPI recipients applying to this
announcement should budget for the same amount as they received in
previous years. However, funding amounts may change. See the paragraph
below for additional information.
New SDPI award applicants should apply for a $25,000 base
amount. However, funding amounts may change based on each specific
Area's funding formula. See the paragraph above.
The funding available for competing and subsequent continuation
awards issued under this announcement is subject to the availability of
appropriations and budgetary priorities of the Agency. The IHS is under
no obligation to make awards to applicants selected for funding under
this announcement.
Anticipated Number of Awards
Approximately 7-20 awards will be issued under this program
announcement.
Period of Performance
The period of performance is for 4 years.
Cooperative Agreement
Cooperative agreements awarded by the Department of Health and
Human Services (HHS) are administered under the same policies as
grants. However, the funding agency, IHS, is anticipated to have
substantial programmatic involvement in the project during the entire
period of performance. Below is a detailed description of the level of
involvement required of the IHS.
Substantial Agency Involvement Description for Cooperative
Agreement
A. DDTP will provide programmatic oversight, including:
1. Award Requirements
a. Create and maintain Best Practices: focused areas for
improvement of diabetes prevention and treatment outcomes in
communities and clinics.
b. Annual Progress Report: Create and provide instructions and
template(s).
2. Data Collection and Analysis
a. IHS Diabetes Care and Outcomes Audit: Provide resources, tools,
support, and training.
b. SDPI Outcomes System (SOS): Create and provide resources, tools,
support, and training. Recipients will use the SOS to track and report
on RKM data for their selected Best Practice.
3. Training, Communication, and Technical Assistance
a. Provide extensive SDPI award-related trainings: Topics include
Application, Annual Progress Report, and others. Most trainings are
provided via live webinars. Webinars will be recorded and made
available on the SDPI website based on importance.
b. Provide updates and announcements via email.
c. Maintain and update the IHS SDPI website (https://www.ihs.gov/sdpi/), which provides information and resources regarding this
cooperative agreement, including:
i. Best Practices.
ii. Additional resources--Documents and links from DDTP and the
Division of Grants Management (DGM).
iii. New to SDPI--Information for new recipients and/or staff.
4. Diabetes Trainings and Resources
a. Provide diabetes-related live, recorded, and online education
developed by the DDTP, designed for clinicians and other health
professionals serving in the Indian health system.
b. Provide clinical updates and announcements via email.
c. Maintain and update the DDTP website, which provides additional
resources for recipients including:
i. Clinician resources--online continuing education opportunities,
diabetes treatment algorithms, IHS Standards of Care and Clinical
Practice Recommendations for Type 2 Diabetes, and IHS Diabetes Care and
Outcomes Audit resources.
ii. Patient education resources--free materials that can be
ordered, printed, or downloaded from the online catalog.
B. The Indian Health Care Improvement Act, amended in 1987,
established that each of the 12 IHS Areas should have an Area Diabetes
Consultant (ADC). The ADCs are health care professionals with expertise
in diabetes. They play a critical role in supporting SDPI diabetes
treatment and prevention activities for their Area including:
1. Oversee SDPI awards within their specified Area to ensure
compliance with programmatic Terms and Conditions.
2. Serve as a liaison between the SDPI award programs, DDTP, and
DGM.
3. Provide training and resources to SDPI recipients. Some
resources may be in the form of additional staff serving as ADC
support.
4. Review or assign a designee to review annual continuation
applications.
5. May serve as the Program Officer for the SDPI award programs in
their IHS Area. The Program Officer is a Federal staff person who is
responsible for managing and monitoring the progress of recipients in
GrantSolutions. If the ADC is not eligible (i.e., not Federal program
staff), another individual may serve as the Program Officer in a
limited capacity. Program Officer's duties include: creating funding
commitments and memos, providing programmatic review/approval of
amendments, and assisting in uploading documents and information as
Grant Notes in GrantSolutions.
Required, Optional, and Allowable Activities
Required
All recipients will need to meet the following requirements:
1. Activities/Services: Recipients must provide activities/services
that:
a. meet the purpose of the SDPI, which is to provide diabetes
treatment
[[Page 68632]]
and/or prevention services and activities for AI/AN communities;
b. are targeted at reducing risk factors for diabetes and diabetes-
related conditions;
c. address diabetes-related issues as identified in the recipient's
application; and
d. use SDPI funds as outlined in the recipient's Budget Narrative.
2. IHS Diabetes Care and Outcomes Audit (Diabetes Audit): SDPI
recipients are required to participate in the Annual Diabetes Audit
(https://www.ihs.gov/diabetes/audit/). Recipients will submit data,
review results, and provide a copy of their Annual Diabetes Audit
Report with their Continuation Applications. Non-clinical or community-
based awardees that are not able to directly participate in the
Diabetes Audit, will need to obtain a copy of the Annual Diabetes Audit
Report from their local facility or Area Diabetes Consultant (https://www.ihs.gov/diabetes/about-us/area-diabetes-consultants-adc/).
3. Best Practices: The Best Practices (https://www.ihs.gov/sdpi/sdpi-community-directed/diabetes-best-practices/) include the latest
scientific findings and recommendations. Recipients must select one
Best Practice and implement activities/services aimed at improving the
associated RKM. Recipients will report on RKM data via the SOS.
4. Collaboration: Recipients must:
a. Consult with and accept guidance from DDTP, DGM, and their ADC/
ADC Support/Federal Program Officer(s) and/or designated assignee(s).
b. Respond promptly to requests for information.
c. Attend required meetings and trainings.
d. Provide short presentations on their processes and successes, as
requested.
e. Keep the entities (see item a. above) informed of emerging
issues, developments, and challenges that may affect the recipient's
ability to comply with the award Terms and Conditions and/or any
requirements.
5. Project Director: Recipients must have an officially approved
Project Director (approved by the Grants Management Officer in
consultation with the Program Official) who has the following
qualifications:
a. Relevant health or wellness education and/or experience.
b. Experience with award program management, including skills in
program coordination, budgeting, reporting, and staff supervision.
c. Working knowledge of diabetes.
The Project Director should routinely update relevant SDPI award
program staff with information and requirements regarding their
program's activities/services.
6. Annual Progress Report: Per DGM policy, the recipient must
complete an annual progress report and submit it within 90 days of the
end of the budget period. The recipient will submit the report by
uploading it into a Grant Note in GrantSolutions. DDTP will post
instructions, template(s), and other information on the SDPI
Application/Report website (https://www.ihs.gov/sdpi/sdpi-community-directed/application-reports/).
7. Required Trainings: Recipients must participate in SDPI required
trainings provided by DDTP. These will primarily be live webinars,
which will be recorded and posted on the SDPI website for those not
able to attend. Recipients will be expected to keep track of
participation (both live and recorded webinars). Information about the
SDPI awardee training requirements will be provided on the SDPI Grant
Training website (https://www.ihs.gov/sdpi/sdpi-community-directed/sdpi-grant-training/).
Optional
1. Optional Trainings: In addition to required training, DDTP also
provides optional trainings. Recipients may participate in SDPI
optional trainings depending on their need for the information that
will be presented. These will primarily be live webinars, which will be
recorded and posted on the SDPI website for those not able to attend.
Recipients are not expected to keep track of participation, but a
training tracking tool is made available and updated regularly,
providing all required and optional trainings hosted by DDTP for the
year. Information about the SDPI recipient training requirements will
be provided on the SDPI Grant Training website (https://www.ihs.gov/sdpi/sdpi-community-directed/sdpi-grant-training/).
2. Diabetes in Indian Country Conference: DDTP occasionally hosts a
conference that provides continuing education opportunities and
collaboration on issues related to improving outcomes for people with
diabetes and those at risk for developing diabetes. SDPI award training
sessions are provided during this conference. SDPI recipient attendance
is encouraged but not required.
Allowable
1. Allowable Activities/Services: There are many types of
activities/services allowed under this award as long as they meet the
activities/services requirement (see Required.1. above) and are within
the scope of work defined in the Project Narrative. For questions,
contact DDTP.
III. Eligibility Information
1. Eligibility
To be eligible for this FY 2024 funding opportunity, applicants
must be one of the following as required by 42 U.S.C. 254c-3(b):
An Indian health program operated by an Indian Tribe or
Tribal organization pursuant to a contract, grant, cooperative
agreement, or compact with the Indian Health Service pursuant to the
Indian Self-Determination and Education Assistance Act [25 U.S.C. 5321
et seq.].
An urban Indian health program operated by an urban Indian
Organization pursuant to a grant or contract with the Indian Health
Service pursuant to title V of the Indian Health Care Improvement Act
[25 U.S.C. 1651 et seq.].
The Indian Health Service. Under this announcement, only
one SDPI grant will be awarded per entity. If a Tribe submits an
application or already has an SDPI grant, their local IHS facility
cannot apply; if the Tribe does not submit an application or does not
already have an SDPI grant, the IHS facility can apply. Tribes that are
awarded grant funds may sub-contract with local IHS facilities to
provide specific clinical services. In this case, the Tribe would be
the primary SDPI grantee and the Federal entity would have a sub-
contract within the Tribe's SDPI grant.
Not a current SDPI grant recipient.
The Division of Grants Management (DGM) will notify any applicants
deemed ineligible.
2. Additional Information on Eligibility
The IHS does not fund concurrent projects. If an applicant is
successful under this announcement, any subsequent applications in
response to other SDPI announcements from the same applicant will not
be funded. Applications on behalf of individuals (including sole
proprietorships) and foreign organizations are not eligible.
Applications deemed ineligible will be disqualified from competitive
review and funding under this funding opportunity.
Note: Please refer to Section IV.2 (Application and Submission
Information/Subsection 2, Content and Form of Application
Submission) for additional proof of applicant status documents
required, such as Tribal Resolutions, proof of nonprofit status,
etc.
[[Page 68633]]
3. Cost Sharing or Matching
The IHS does not require matching funds or cost sharing for grants
or cooperative agreements.
4. Other Requirements
Applications with budget requests that exceed the highest dollar
amount outlined under Section II Award Information, Estimated Funds
Available, or exceed the period of performance outlined under Section
II Award Information, Period of Performance, are considered not
responsive and will not be reviewed. The DGM will notify the applicant.
Additional Required Documentation
Tribes and Tribal Organizations
Tribal Resolution
The DGM must receive an official, signed Tribal Resolution prior to
issuing a Notice of Award (NoA) to any Tribe or Tribal organization
selected for funding. An applicant that is proposing a project
affecting another Indian Tribe must include resolutions from all
affected Tribes to be served. However, if an official signed Tribal
Resolution cannot be submitted with the application prior to the
application deadline date, a draft Tribal Resolution must be submitted
with the application by the deadline date in order for the application
to be considered complete and eligible for review. The draft Tribal
Resolution is not in lieu of the required signed resolution, but is
acceptable until a signed resolution is received. If an application
without a signed Tribal Resolution is selected for funding, the
applicant will be contacted by the Grants Management Specialist (GMS)
listed in this funding announcement and given 90 days to submit an
official, signed Tribal Resolution to the GMS. If the signed Tribal
Resolution is not received within 90 days, the award will be forfeited.
Applicants organized with a governing structure other than a Tribal
council may submit an equivalent document commensurate with their
governing organization.
Proof of Nonprofit Status
Organizations claiming nonprofit status must submit a current copy
of the 501(c)(3) Certificate with the application.
IV. Application and Submission Information
Grants.gov uses a Workspace model for accepting applications. The
Workspace consists of several online forms and three forms in which to
upload documents--Project Narrative, Budget Narrative, and Other
Documents. Give your files brief descriptive names. The filenames are
key in finding specific documents during the objective review and in
processing awards. Upload all requested and optional documents
individually, rather than combining them into a package. Creating a
package creates confusion when trying to find specific documents. Such
confusion can contribute to delays in processing awards, and could lead
to lower scores during the objective review.
1. Obtaining Application Materials
The application package and detailed instructions for this
announcement are available at https://www.Grants.gov.
Please direct questions regarding the application process to
[email protected].
2. Content and Form Application Submission
Mandatory documents for all applications are listed below. An
application is incomplete if any of the listed mandatory documents are
missing. Incomplete applications will not be reviewed.
Application forms:
1. SF-424, Application for Federal Assistance.
2. SF-424A, Budget Information--Non-Construction Programs.
3. SF-424B, Assurances--Non-Construction Programs.
4. Project Abstract Summary Form.
Project Narrative (not to exceed 18 pages). See Section
IV.2.A, Project Narrative for more information.
Budget Justification and Narrative (not to exceed seven
pages). See Section IV.2.B, Budget Narrative for instructions.
One-page Timeframe Chart.
2022 and 2023 Annual Diabetes Audit reports (DRAFT report
for 2023 is acceptable) or copies of Audit waivers provided by DDTP.
Letter(s) of Support from one or more of the following:
1. Board of Directors (Urban Indian health programs).
2. Chief Executive Officer (IHS facilities).
3. Tribes served (highly recommended for IHS facilities).
Biographical sketches for all Key Personnel.
Key contacts form for diabetes program coordinator.
Certification Regarding Lobbying (GG-Lobbying Form).
The documents listed here may be required. Please read this list
carefully.
Tribal Resolution(s) as described in Section III,
Eligibility.
501(c)(3) Certificate.
Disclosure of Lobbying Activities (SF-LLL), if applicant
conducts reportable lobbying.
Copy of current Negotiated Indirect Cost (IDC) rate
agreement (required in order to receive IDC).
Contractor/Consultant resumes or qualifications and scope
of work.
Documentation of current Office of Management and Budget
(OMB) Financial Audit (if applicable).
Acceptable forms of documentation include:
1. Email confirmation from Federal Audit Clearinghouse (FAC) that
audits were submitted; or
2. Face sheets from audit reports. Applicants can find these on the
FAC website at https://facdissem.census.gov/.
Additional documents can be uploaded as Other Attachments in
Grants.gov. These can include:
Work plan, logic model, and/or timeline for proposed
objectives.
Position descriptions for key staff.
Resumes of key staff that reflect current duties.
Organizational chart.
Map of area identifying project location(s).
Additional documents to support narrative (for example,
data tables, and key news articles).
Public Policy Requirements
All Federal public policies apply to IHS grants and cooperative
agreements. Pursuant to 45 CFR 80.3(d), an individual shall not be
deemed subjected to discrimination by reason of their exclusion from
benefits limited by Federal law to individuals eligible for benefits
and services from the IHS. See https://www.hhs.gov/grants/grants/grants-policies-regulations/.
Requirements for Project and Budget Narratives and Other Programmatic
Reports
A. Project Narrative
This narrative should be a separate document that is no more than
18 pages and must: (1) have consecutively numbered pages; (2) use black
font 12 points or larger (applicants may use 10-point font for tables);
(3) be single-spaced; and (4) be formatted to fit standard letter paper
(8\1/2\ x 11 inches). DDTP provides an optional PDF template on the
SDPI Application website at https://www.ihs.gov/sdpi/sdpi-community-directed/application-reports/, which applicants can use to provide the
required information instead of developing their own format.
Be sure to succinctly answer all questions listed under the
evaluation
[[Page 68634]]
criteria (refer to Section V.1, Evaluation Criteria), and place all
responses and required information in the correct section noted below
or they will not be considered or scored. If the narrative exceeds the
overall page limit, the reviewers will be directed to ignore any
content beyond the page limit. The 18-page limit for the project
narrative does not include the work plan, standard forms, Tribal
Resolutions, budget, budget narratives, and/or other items. Page limits
for each section within the project narrative are guidelines, not hard
limits.
There are six parts to the Project Narrative:
Part A: Program Identifiers/Experience (Limit--2 pages)
Information to identify your program including past experience with
diabetes treatment and preventions in the AI/AN Communities (include
years of experience), geographic location, food resources, and
relationship or role with local Indian health clinic.
Part B: Needs Assessment (Limit--3 pages)
Section 1: Diabetes Needs
Assessment--identify key diabetes-related health issues and
diabetes prevalence.
Section 2: Review of Diabetes Audit Reports
Obtain and review of 2022 and 2023 Annual Diabetes Audit Reports,
to provide 2-3 items/elements that need to be improved and how your
program will address those items/elements.
Section 3: Challenges
Identify and describe challenges your program experiences or may
face related to prevention and/or treatment of diabetes.
Part C: Program Support and Resources (Limit--3 pages)
Section 1: Leadership Support
Identify at least one organization administrator or Tribal leaders
(other than your Program Coordinator) who has agreed to support your
SDPI program for 2024 and describe how they will be actively involved
with your program.
Section 2: Key Personnel
List all key personnel that will be involved in your program's
activities/services. This may be your ``Diabetes Team.'' You must also
separately provide a brief resume or biographical sketch for all key
personnel listed.
Section 3: Partnerships and Collaborations
List current active partnerships related to your SDPI program and
describe any new partnerships and collaborations that your SDPI program
is planning to implement. Include information about how these partners
and collaborators will contribute to the activities/services you plan
to provide.
Part D: SDPI Diabetes Best Practice (Limit--3 pages)
Section 1: Best Practice Selection
Applicants must select one Best Practice that addresses one of the
needs that was identified in the needs assessment (Part B). There is a
list of all the Best Practices on the Best Practices website: https://www.ihs.gov/sdpi/sdpi-community-directed/diabetes-best-practices/. For
each Best Practice, there is a brief statement on the importance, RKM
information, and guidance for selecting a Target Group, and tools and
resources.
Section 2: Best Practice Activities
Provide a list of activity(ies)/service(s) to implement that would
improve the RKM of the selected Best Practice. Each activity/service
should include a brief description and a timeline for implementation.
Section 3: Target Group Number and Description
Recipients will be required to report RKM data for one Target Group
for their selected Best Practice. A Target Group is the largest number
of patients/participants that you can realistically include in the
activities/services you provided in the Best Practice activities for
the budget period. The following should be considered in selecting your
Target Group:
a. The size and characteristics (e.g., ages, health status,
settings, locations) of the community or patient population that you
are going to draw your Target Group from;
b. Intensity of the activities/services you plan to do;
c. and SDPI funding and other resources available to provide
activities/services.
Part E: Activities/Services not related to selected Best Practice
(Optional. Limit--5 pages)
Provide information for up to five major activities/services,
supported by SDPI funds, to address needs that were identified in the
needs assessment (Part B). Activities/services reported here should be
based on the following criteria:
a. Use the most award funding and program time.
b. Address significant needs/challenges.
Part F: Additional Information (Limit--2 pages)
Provide additional information as specified by program office.
B. Budget Narrative (Limit--7 pages)
Provide a budget narrative that explains the amounts requested for
each line item of the budget from the SF-424A (Budget Information for
Non-Construction Programs) for the first year of the project. The
applicant can submit with the budget narrative a more detailed
spreadsheet than is provided by the SF-424A (the spreadsheet will not
be considered part of the budget narrative). The budget narrative
should specifically describe how each item will support the achievement
of proposed objectives. Be very careful about showing how each item in
the ``Other'' category is justified. For subsequent budget years (see
Multi-Year Project Requirements in Section V.1, Application Review
Information, Evaluation Criteria), the additional pages should
highlight the changes from the first year or clearly indicate that
there are no substantive budget changes during the period of
performance. Do NOT use the budget narrative to expand the project
narrative.
C. IHS Diabetes Care and Outcomes Audit
The IHS Diabetes Care and Outcomes Audit is a process to assess
care and health outcomes for AI/AN people with diagnosed diabetes. IHS,
Tribal, and Urban Indian health care facilities nationwide participate
in this process each year by auditing medical records for their
patients with diabetes. Applicants who are able to must submit copies
of their local facility's 2022 and 2023 Annual Diabetes Audit reports
or copies of the Audit waivers provided by DDTP.
Annual Diabetes Audit reports can be obtained in the following
ways:
a. Via the WebAudit: https://www.ihs.gov/diabetes/audit/.
b. Request from their local facility.
c. Request from their ADC: https://www.ihs.gov/diabetes/about-us/area-diabetes-consultants-adc/.
For programs that received Audit waivers, these can be found in
GrantSolutions (as a Grant Note).
If the applicant is unable to obtain their local facility's 2022
and 2023 Annual Diabetes Audit Reports, they must provide an
explanation in their
[[Page 68635]]
Project Narrative (Part B). For any questions, contact DDTP.
3. Submission Dates and Times
Applications must be submitted through Grants.gov by 11:59 p.m.
Eastern Time on the Application Deadline Date. Any application received
after the application deadline will not be accepted for review.
Grants.gov will notify the applicant via email if the application is
rejected.
If technical challenges arise and assistance is required with the
application process, contact Grants.gov Customer Support (see contact
information at https://www.Grants.gov). If problems persist, contact
Mr. Paul Gettys, Deputy Director, DGM, by email at [email protected]. Please
be sure to contact Mr. Gettys at least 10 days prior to the application
deadline. Please do not contact the DGM until you have received a
Grants.gov tracking number. In the event you are not able to obtain a
tracking number, call the DGM as soon as possible by email at
[email protected].
The IHS will not acknowledge receipt of applications.
4. Intergovernmental Review
Executive Order 12372 requiring intergovernmental review is not
applicable to this program.
5. Funding Restrictions
Pre-award costs are allowable up to 90 days before the
start date of the award provided the costs are otherwise allowable if
awarded. Pre-award costs are incurred at the risk of the applicant.
The available funds are inclusive of direct and indirect
costs.
Only one cooperative agreement will be awarded per
applicant.
6. Electronic Submission Requirements
All applications must be submitted via Grants.gov. Please use the
https://www.Grants.gov website to submit an application. Find the
application by selecting the ``Search Grants'' link on the homepage.
Follow the instructions for submitting an application under the Package
tab. No other method of application submission is acceptable.
If you cannot submit an application through Grants.gov, you must
request a waiver prior to the application due date. You must submit
your waiver request by email to [email protected]. Your waiver request must
include clear justification for the need to deviate from the required
application submission process. The IHS will not accept any
applications submitted through any means outside of Grants.gov without
an approved waiver.
If the DGM approves your waiver request, you will receive a
confirmation of approval email containing submission instructions. You
must include a copy of the written approval with the application
submitted to the DGM. Applications that do not include a copy of the
waiver approval from the DGM will not be reviewed. The Grants
Management Officer of the DGM will notify the applicant via email of
this decision. Applications submitted under waiver must be received by
the DGM no later than 5:00 p.m. Eastern Time on the Application
Deadline Date. Late applications will not be accepted for processing.
Applicants that do not register for both the System for Award
Management (SAM) and Grants.gov and/or fail to request timely
assistance with technical issues will not be considered for a waiver to
submit an application via alternative method.
Please be aware of the following:
Please search for the application package in https://www.Grants.gov by entering the Assistance Listing number or the Funding
Opportunity Number. Both numbers are located in the header of this
announcement.
If you experience technical challenges while submitting
your application, please contact Grants.gov Customer Support (see
contact information at https://www.Grants.gov).
Upon contacting Grants.gov, obtain a tracking number as
proof of contact. The tracking number is helpful if there are technical
issues that cannot be resolved and a waiver from the agency must be
obtained.
Applicants are strongly encouraged not to wait until the
deadline date to begin the application process through Grants.gov as
the registration process for SAM and Grants.gov could take up to 20
working days.
Please follow the instructions on Grants.gov to include
additional documentation that may be requested by this funding
announcement.
Applicants must comply with any page limits described in
this funding announcement.
After submitting the application, you will receive an
automatic acknowledgment from Grants.gov that contains a Grants.gov
tracking number. The IHS will not notify you that the application has
been received.
System for Award Management
Organizations that are not registered with the System for Award
Management (SAM) must access the SAM online registration through the
SAM home page at https://sam.gov. Organizations based in the United
States (U.S.) will also need to provide an Employer Identification
Number from the Internal Revenue Service that may take an additional 2-
5 weeks to become active. Please see SAM.gov for details on the
registration process and timeline. Registration with the SAM is free of
charge but can take several weeks to process. Applicants may register
online at https://sam.gov.
Unique Entity Identifier
Your SAM.gov registration now includes a Unique Entity Identifier
(UEI), generated by SAM.gov, which replaces the DUNS number obtained
from Dun and Bradstreet. SAM.gov registration no longer requires a DUNS
number.
Check your organization's SAM.gov registration as soon as you
decide to apply for this program. If your SAM.gov registration is
expired, you will not be able to submit an application. It can take
several weeks to renew it or resolve any issues with your registration,
so do not wait.
Check your Grants.gov registration. Registration and role
assignments in Grants.gov are self-serve functions. One user for your
organization will have the authority to approve role assignments, and
these must be approved for active users in order to ensure someone in
your organization has the necessary access to submit an application.
The Federal Funding Accountability and Transparency Act of 2006, as
amended (``Transparency Act''), requires all HHS recipients to report
information on sub-awards. Accordingly, all IHS recipients must notify
potential first-tier sub-recipients that no entity may receive a first-
tier sub-award unless the entity has provided its UEI number to the
prime recipient organization. This requirement ensures the use of a
universal identifier to enhance the quality of information available to
the public pursuant to the Transparency Act.
Additional information on implementing the Transparency Act,
including the specific requirements for SAM, are available on the DGM
Grants Management, Policy Topics web page at https://www.ihs.gov/dgm/policytopics/.
V. Application Review Information
Possible points assigned to each section are noted in parentheses.
The project narrative and budget narrative should include only the
first year of activities; information for multi-year projects should be
included as a separate document. See ``Multi-year Project
Requirements'' at the end of this section for more information. The
project narrative should be written in a manner that is clear to
outside reviewers unfamiliar with prior related activities of the
applicant. It should be well
[[Page 68636]]
organized, succinct, and contain all information necessary for
reviewers to fully understand the project. Attachments requested in the
criteria do not count toward the page limit for the narratives. Points
will be assigned to each evaluation criteria adding up to a total of
100 possible points. Points are assigned as follows:
1. Evaluation Criteria
A. Introduction and Need for Assistance (15 points)
(i) Program Identifiers/Experience (Project Narrative Part A)
(1) Was program identifier information adequately provided?
(2) Did applicant provide sufficient information to establish their
location and relationship to their local Indian Health Clinic?
(ii) Needs Assessment (Project Narrative Part B)
(1) Did the applicant adequately describe the key diabetes-related
health issues identified by their community/leadership?
(2) Were numbers provided for applicant's local user population and
people with diagnosed diabetes?
(3) Did the applicant appropriately identify Diabetes Audit items
(or diabetes-related issues if Audit Reports were not provided) that
need to be improved?
(4) Did the applicant adequately describe how they will address the
Diabetes Audit items or diabetes-related issues that need to be
improved?
(5) Did the applicant adequately describe challenges?
B. Project Objective(s), Work Plan and Approach (30 points)
(i) SDPI Diabetes Best Practice (Project Narrative Part D)
(1) Did the applicant provide an adequate description of
activities/services to improve the RKM?
(2) Are the activities/services proposed appropriate for the
selected Best Practice and Target Group?
(3) Do the planned activities/services appear to be reasonable
given the constraints of timeframe, resources, and staff?
(ii) If Applicable: Activities/Services Not Related to Selected Best
Practice (Project Narrative Part E)
(1) Do activities/services address diabetes-related issues
identified in the needs assessment in Part B?
(2) Are activities/services aimed at reducing risk factors for
diabetes and/or related conditions?
(3) Are activities/services adequately described?
(4) Do the planned activities/services appear to be reasonable
given the constraints of timeframe, resources, and staff?
C. Program Evaluation (15 points)
(i) SDPI Diabetes Best Practice (Project Narrative Part D)
(1) Was a Best Practice selected?
(2) Was the number of patients/participants in the Target Group
provided?
(3) Was the Target Group adequately described?
(4) Are the Target Group and number of patients/participants
reasonable given the information the applicant provided in their needs
assessment and program resources sections?
(ii) If Applicable: Activities/Services Not Related to Selected Best
Practice (Project Narrative Part E)
(1) Was an appropriate target group identified for each activity/
service?
(2) Did the applicant specify how improvement and reduction in risk
factors will be evaluated?
D. Organizational Capabilities, Key Personnel, and Qualifications (30
points)
(i) Program Identifiers/Experience (Project Narrative Part A)
(1) Does the applicant have experience with diabetes treatment and
prevention services in AI/AN communities?
(2) Is the experience provided recent? (within 5 years)
(ii) Program Support (Project Narrative Part C)
(1) Does the program propose to provide sufficient and appropriate
staff to carry out planned activities?
(2) Did the applicant identify an appropriate organization
administrator or Tribal leader, other than the Program Coordinator, to
support their SDPI program?
(3) Did the applicant describe how this leader will be involved
with the SDPI program?
(4) Did the applicant provide appropriate and adequate information
about key personnel in the Project Narrative?
(5) Did the applicant provide appropriate and adequate information
about partnerships and collaborations in the Project Narrative?
E. Categorical Budget and Budget Justification (10 points)
(i) Does the budget match the scope of work described in the
Project Narrative?
(ii) Was each line item adequately specified and justified?
(iii) Do funding totals match between the SF-424A, budget line
item, and justification?
(iv) Is the budget reasonable and realistic?
Multi-Year Project Requirements
Applications must include a brief project narrative and budget (one
additional page per year) addressing the developmental plans for each
additional year of the project. This attachment will not count as part
of the project narrative or the budget narrative.
2. Review and Selection
Each application will be prescreened for eligibility and
completeness as outlined in this funding announcement. The Review
Committee (RC) will review applications that meet the eligibility
criteria. The RC will review the applications for merit based on the
evaluation criteria. Incomplete applications and applications that are
not responsive to the administrative thresholds (budget limit, period
of performance limit) will not be referred to the RC and will not be
funded. The DGM will notify the applicant of this determination.
Applicants must address all program requirements and provide all
required documentation.
3. Notifications of Disposition
All applicants will receive an Executive Summary Statement from the
IHS DDTP within 30 days of the conclusion of the review outlining the
strengths and weaknesses of their application. The summary statement
will be sent to the Authorizing Official identified on the face page
(SF-424) of the application.
A. Award Notices for Funded Applications
The NoA is the authorizing document for which funds are dispersed
to the approved entities and reflects the amount of Federal funds
awarded, the purpose of the award, the terms and conditions of the
award, the effective date of the award, the budget period, and period
of performance. Each entity approved for funding must have a user
account in GrantSolutions in order to retrieve the NoA. Please see the
Agency Contacts list in Section VII for the systems contact
information.
B. Approved but Unfunded Applications
Approved applications not funded due to lack of available funds
will be held for 1 year. If funding becomes
[[Page 68637]]
available during the course of the year, the application may be
reconsidered.
Note: Any correspondence other than the official NoA executed by
an IHS grants management official announcing to the project director
that an award has been made to their organization is not an
authorization to implement their program on behalf of the IHS.
VI. Award Administration Information
1. Administrative Requirements
Awards issued under this announcement are subject to, and are
administered in accordance with, the following regulations and
policies:
A. The criteria as outlined in this program announcement.
B. Administrative Regulations for Awards:
Uniform Administrative Requirements, Cost Principles, and
Audit Requirements for HHS Awards currently in effect or implemented
during the period of award, other Department regulations and policies
in effect at the time of award, and applicable statutory provisions. At
the time of publication, this includes 45 CFR part 75, at https://www.govinfo.gov/content/pkg/CFR-2022-title45-vol1/pdf/CFR-2022-title45-vol1-part75.pdf.
If you receive an award, HHS may terminate it if any of
the conditions in 2 CFR 200.340(a)(1)-(4) are met. Please review all
HHS regulatory provisions for Termination at 45 CFR 75.372, at the time
of this publication located at https://www.govinfo.gov/content/pkg/CFR-2022-title45-vol1/pdf/CFR-2022-title45-vol1-sec75-372.pdf.
C. Grants Policy:
HHS Grants Policy Statement, Revised January 2007, at
https://www.hhs.gov/sites/default/files/grants/grants/policies-regulations/hhsgps107.pdf.
D. Cost Principles:
Uniform Administrative Requirements for HHS Awards, ``Cost
Principles,'' at 45 CFR part 75 subpart E, at the time of this
publication located at https://www.govinfo.gov/content/pkg/CFR-2022-title45-vol1/pdf/CFR-2022-title45-vol1-part75-subpartE.pdf.
E. Audit Requirements:
Uniform Administrative Requirements for HHS Awards,
``Audit Requirements,'' at 45 CFR part 75 subpart F, at the time of
this publication located at https://www.govinfo.gov/content/pkg/CFR-2022-title45-vol1/pdf/CFR-2022-title45-vol1-part75-subpartF.pdf.
F. As of August 13, 2020, 2 CFR part 200 was updated to include a
prohibition on certain telecommunications and video surveillance
services or equipment. This prohibition is described in 2 CFR 200.216.
This will also be described in the terms and conditions of every IHS
grant and cooperative agreement awarded on or after August 13, 2020.
2. Indirect Costs
This section applies to all recipients that request reimbursement
of IDC in their application budget. In accordance with HHS Grants
Policy Statement, Part II-27, the IHS requires applicants to obtain a
current IDC rate agreement and submit it to the DGM prior to the DGM
issuing an award. The rate agreement must be prepared in accordance
with the applicable cost principles and guidance as provided by the
cognizant agency or office. A current rate covers the applicable award
activities under the current award's budget period. If the current rate
agreement is not on file with the DGM at the time of award, the IDC
portion of the budget will be restricted. The restrictions remain in
place until the current rate agreement is provided to the DGM. Per 2
CFR 200.414(f) Indirect (F&A) costs,
any non-Federal entity (NFE) [i.e., applicant] that does not have a
current negotiated rate, . . . may elect to charge a de minimis rate
of 10 percent of modified total direct costs which may be used
indefinitely. As described in Section 200.403, costs must be
consistently charged as either indirect or direct costs, but may not
be double charged or inconsistently charged as both. If chosen, this
methodology once elected must be used consistently for all Federal
awards until such time as the NFE chooses to negotiate for a rate,
which the NFE may apply to do at any time.
Electing to charge a de minimis rate of 10 percent can be used by
applicants that have received an approved negotiated indirect cost rate
from HHS or another cognizant Federal agency. Applicants awaiting
approval of their indirect cost proposal may request the 10 percent de
minimis rate. When the applicant chooses this method, costs included in
the indirect cost pool must not be charged as direct costs to the
award. Available funds are inclusive of direct and appropriate indirect
costs. Approved indirect funds are awarded as part of the award amount,
and no additional funds will be provided.
Generally, IDC rates for IHS recipients are negotiated with the
Division of Cost Allocation at https://rates.psc.gov/ or the Department
of the Interior (Interior Business Center) at https://ibc.doi.gov/ICS/tribal. For questions regarding the indirect cost policy, please write
to [email protected].
3. Reporting Requirements
The recipient must submit required reports consistent with the
applicable deadlines. Failure to submit required reports within the
time allowed may result in suspension or termination of an active
award, withholding of additional awards for the project, or other
enforcement actions such as withholding of payments or converting to
the reimbursement method of payment. Continued failure to submit
required reports may result in the imposition of special award
provisions and/or the non-funding or non-award of other eligible
projects or activities. This requirement applies whether the
delinquency is attributable to the failure of the recipient
organization or the individual responsible for preparation of the
reports. Per DGM policy, all reports must be submitted electronically
by attaching them as a ``Grant Note'' in GrantSolutions. Personnel
responsible for submitting reports will be required to obtain a login
and password for GrantSolutions. Please use the form under the
Recipient User section of https://www.grantsolutions.gov/home/getting-started-request-a-user-account/. Download the Recipient User Account
Request Form, fill it out completely, and submit it as described on the
web page and in the form.
The reporting requirements for this program are noted below.
A. Progress Reports
Program progress reports are required annually. The progress
reports are due within 30 days after the reporting period ends
(specific dates will be listed in the NoA Terms and Conditions). These
reports must include a brief comparison of actual accomplishments to
the goals established for the period, a summary of progress to date or,
if applicable, provide sound justification for the lack of progress,
and other pertinent information as required. Recipient must submit a
final report within 120 days of the period of performance end date.
Instructions, template(s), and other information will be posted on the
SDPI website at https://www.ihs.gov/sdpi/sdpi-community-directed/application-reports/.
B. Financial Reports
Federal Financial Reports are due 90 days after the end of each
budget period, and a final report is due 120 days after the end of the
period of performance.
Recipients are responsible and accountable for reporting accurate
information on all required reports: the Progress Reports and the
Federal Financial Report.
[[Page 68638]]
Failure to submit timely reports may result in adverse award
actions blocking access to funds.
C. Data Collection and Reporting
SOS RKM Data Requirements: Data for the selected Best Practice RKM
will be submitted using the SOS. Recipients will submit results for
their RKM for their selected Best Practice into this system at the
start (baseline) and end (final) of the budget period, with the option
to submit more frequently. The system will generate SOS RKM data
reports to meet the SDPI outcomes reporting requirements. These results
will be stored in the system and will be accessible to program staff,
as needed. Recipients will need to appoint at least one person in their
program to get access to and submit data into the SOS.
i. Baseline data: Data is to be submitted into the SOS by the last
business day of February each year (e.g., 2024 baseline data will be by
Thursday, February 29, 2024). A report from the SOS showing baseline
data submission will be due with continuation applications.
ii. Final data: Data for the prior budget period is to be submitted
into the SOS by the last business day of January, each year (e.g., 2024
final data will be due by Friday, January 31, 2025). A report from the
SOS showing baseline and final data submission will be due with the
Annual Progress Report.
Refer to the SDPI website (https://www.ihs.gov/sdpi/) for the
latest information on report templates, due dates, webinars and
submission instructions.
Diabetes Care and Outcomes Audit: SDPI recipients are required to
participate in the Annual Diabetes Audit (https://www.ihs.gov/diabetes/audit/). Recipients will submit data, review results, and provide a
copy of their Annual Diabetes Audit Report with their annual SDPI
applications. Diabetes Annual Audit data are to be submitted into the
WebAudit each year around mid-March, (e.g., 2024 Audit data collecting
annual data will be due approximately March 15, 2024). Non-clinical or
community-based recipients, that are not able to directly participate
in the Diabetes Audit, will need to obtain a copy of the Annual
Diabetes Audit Report from their local facility or Area Diabetes
Consultant (https://www.ihs.gov/diabetes/about-us/area-diabetes-consultants-adc/).
D. Federal Sub-award Reporting System (FSRS)
This award may be subject to the Transparency Act sub-award and
executive compensation reporting requirements of 2 CFR part 170.
The Transparency Act requires the OMB to establish a single
searchable database, accessible to the public, with information on
financial assistance awards made by Federal agencies. The Transparency
Act also includes a requirement for recipients of Federal grants to
report information about first-tier sub-awards and executive
compensation under Federal assistance awards.
The IHS has implemented a Term of Award into all IHS Standard Terms
and Conditions, NoAs, and funding announcements regarding the FSRS
reporting requirement. This IHS Term of Award is applicable to all IHS
grant and cooperative agreements issued on or after October 1, 2010,
with a $25,000 sub-award obligation threshold met for any specific
reporting period.
For the full IHS award term implementing this requirement and
additional award applicability information, visit the DGM Grants
Management website at https://www.ihs.gov/dgm/policytopics/.
E. Non-Discrimination Legal Requirements for Recipients of Federal
Financial Assistance (FFA)
If you receive an award, you must follow all applicable
nondiscrimination laws. You agree to this when you register in SAM.gov.
You must also submit an Assurance of Compliance (HHS-690). To learn
more, see https://www.hhs.gov/civil-rights/for-providers/laws-regulations-guidance/laws/. Pursuant to 45 CFR 80.3(d), an
individual shall not be deemed subjected to discrimination by reason of
their exclusion from benefits limited by Federal law to individuals
eligible for benefits and services from the IHS.
F. Federal Awardee Performance and Integrity Information System
(FAPIIS)
The IHS is required to review and consider any information about
the applicant that is in the FAPIIS at https://www.fapiis.gov/fapiis/#/home before making any award in excess of the simplified acquisition
threshold (currently $250,000) over the period of performance. An
applicant may review and comment on any information about itself that a
Federal awarding agency previously entered. The IHS will consider any
comments by the applicant, in addition to other information in FAPIIS,
in making a judgment about the applicant's integrity, business ethics,
and record of performance under Federal awards when completing the
review of risk posed by applicants, as described in 45 CFR 75.205.
As required by 45 CFR part 75 Appendix XII of the Uniform Guidance,
NFEs are required to disclose in FAPIIS any information about criminal,
civil, and administrative proceedings, and/or affirm that there is no
new information to provide. This applies to NFEs that receive Federal
awards (currently active grants, cooperative agreements, and
procurement contracts) greater than $10 million for any period of time
during the period of performance of an award/project.
Mandatory Disclosure Requirements
As required by 2 CFR part 200 of the Uniform Guidance, and the HHS
implementing regulations at 45 CFR part 75, the IHS must require an NFE
or an applicant for a Federal award to disclose, in a timely manner, in
writing to the IHS or pass-through entity all violations of Federal
criminal law involving fraud, bribery, or gratuity violations
potentially affecting the Federal award.
All applicants and recipients must disclose in writing, in a timely
manner, to the IHS and to the HHS Office of Inspector General all
information related to violations of Federal criminal law involving
fraud, bribery, or gratuity violations potentially affecting the
Federal award. 45 CFR 75.113.
Disclosures must be sent in writing to:
U.S. Department of Health and Human Services Indian Health Service,
Division of Grants Management, ATTN: Marsha Brookins, Director, 5600
Fishers Lane, Mail Stop: 09E70, Rockville, MD 20857, (Include
``Mandatory Grant Disclosures'' in subject line), Office: (301) 443-
4750, Fax: (301) 594-0899, Email: [email protected]
AND
U.S. Department of Health and Human Services, Office of Inspector
General, ATTN: Mandatory Grant Disclosures, Intake Coordinator, 330
Independence Avenue SW, Cohen Building, Room 5527, Washington, DC
20201, URL: https://oig.hhs.gov/fraud/report-fraud/, (Include
``Mandatory Grant Disclosures'' in subject line), Fax: (202) 205-0604
(Include ``Mandatory Grant Disclosures'' in subject line) or Email:
[email protected]
Failure to make required disclosures can result in any of the
remedies described in 45 CFR 75.371 Remedies for noncompliance,
including suspension or debarment (see 2 CFR part 180 and 2 CFR part
376).
[[Page 68639]]
VII. Agency Contacts
1. Questions on the programmatic issues may be directed to:
Applicant's Area Diabetes Consultant: https://www.ihs.gov/diabetes/about-us/area-diabetes-consultants-adc/, IHS Division of Diabetes
Treatment and Prevention, 5600 Fishers Lane, Mailstop: 08N34A,
Rockville, MD 20857, Phone: (844) 447-3387, Fax: (301) 594-6213, Email:
[email protected] and [email protected], Division of Diabetes website:
https://www.ihs.gov/diabetes/ and https://www.ihs.gov/sdpi/
2. Questions on awards management and fiscal matters may be
directed to:
Indian Health Service, Division of Grants Management, 5600 Fishers
Lane, Mail Stop: 09E70, Rockville, MD 20857, Email: [email protected].
3. For technical assistance with Grants.gov, please contact the
Grants.gov help desk at (800) 518-4726, or by email at
[email protected].
4. For technical assistance with GrantSolutions, please contact the
GrantSolutions help desk at (866) 577-0771, or by email at
[email protected].
VIII. Other Information
The Public Health Service strongly encourages all grant,
cooperative agreement, and contract recipients to provide a smoke-free
workplace and promote the non-use of all tobacco products. In addition,
Public Law 103-227, the Pro-Children Act of 1994, prohibits smoking in
certain facilities (or in some cases, any portion of the facility) in
which regular or routine education, library, day care, health care, or
early childhood development services are provided to children. This is
consistent with the HHS mission to protect and advance the physical and
mental health of the American people.
Roselyn Tso,
Director, Indian Health Service.
[FR Doc. 2023-22057 Filed 10-3-23; 8:45 am]
BILLING CODE 4166-14-P